{"content":"<li class=\"n-box-item date-title\" data-end=\"1508558399\" data-start=\"1508472000\" data-txt=\"Monday, December 23, 2019\">Friday, October 20, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3302769\" data-ts=\"1508541336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBCF\" target=\"_blank\">SBCF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302769-seacoast-closes-on-purchase-of-northstar-banking\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seacoast closes on purchase of NorthStar Banking</a></h4><ul>   <li>Seacoast (<a href=\"http://seekingalpha.com/symbol/SBCF\" target=\"_blank\">SBCF</a> <font color='green'>+1.8%</font>) has <a href=\"https://seekingalpha.com/pr/16975342-seacoast-completes-acquisition-northstar-banking-corporation\" target=\"_blank\">closed on an acquisition</a> for NorthStar Banking Corp. of about $32.5M in cash and stock.</li>    <li>NSBC's subsidiary NorthStar Bank has been absorbed into Seacoast Bank, effective today.</li>    <li>That adds $213.7M in assets, $169.6M in deposits and $138.7M in loans to Seacoast, boosting its total assets 4% to $5.5B.</li>    <li>For each NSBC share, NSBC shareholders got the right to receive 0.5605 of a share of Seacoast common stock and $2.40 in cash (about $16.12/share of NSBC stock).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302769\" data-linked=\"Seacoast closes on purchase of NorthStar Banking\" data-tweet=\"$SBCF - Seacoast closes on purchase of NorthStar Banking https://seekingalpha.com/news/3302769-seacoast-closes-on-purchase-of-northstar-banking?source=tweet\" data-url=\"https://seekingalpha.com/news/3302769-seacoast-closes-on-purchase-of-northstar-banking\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302760\" data-ts=\"1508535856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNXR\" target=\"_blank\">CNXR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302760-connecture-to-delist-from-nasdaq-move-to-otc-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Connecture to delist from Nasdaq, move to OTC market</a></h4><ul>     <li>Connecture (<a href='https://seekingalpha.com/symbol/CNXR' title='Connecture'>OTC:CNXR</a>) <font color='red'>-40.8%</font> after-hours as it announces plans to <a href=\"https://seekingalpha.com/pr/16975282-connecture-inc-announces-intention-voluntarily-delist-nasdaq-global-market-list-otcqx-market\" target=\"_blank\">voluntarily delist</a> from the Nasdaq Global Market and list on the OTCQX market.</li>     <li>CNXR had been notified that it was not in compliance with continued listing standards for the $15M minimum market cap and the $1/share minimum bid price.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302760\" data-linked=\"Connecture to delist from Nasdaq, move to OTC market\" data-tweet=\"$CNXR - Connecture to delist from Nasdaq, move to OTC market https://seekingalpha.com/news/3302760-connecture-to-delist-from-nasdaq-move-to-otc-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3302760-connecture-to-delist-from-nasdaq-move-to-otc-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302759\" data-ts=\"1508535369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302759-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/AIMT' title='Aimmune Therapeutics'>AIMT</a> <font color='green'>+44.1%</font>. <a href='https://seekingalpha.com/symbol/KALV' title='KalVista Pharmaceticals, Inc.'>KALV</a> <font color='green'>+3.9%</font>. <a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color='green'>+3.1%</font>. <a href='https://seekingalpha.com/symbol/FLXN' title='Flexion Therapeutics, Inc.'>FLXN</a> <font color='green'>+3.1%</font>. <a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a> <font color='green'>+1.9%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies'>DBVT</a> <font color='red'>-51.1%</font>. <a href='https://seekingalpha.com/symbol/CRZO' title='Carrizo Oil & Gas, Inc.'>CRZO</a> <font color='red'>-2.4%</font>. <a href='https://seekingalpha.com/symbol/ZNGA' title='Zynga'>ZNGA</a> <font color='red'>-1.3%</font>. <a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='red'>-1.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302759\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$AIMT $KALV $AVP - After Hours Gainers / Losers https://seekingalpha.com/news/3302759-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3302759-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302758\" data-ts=\"1508535350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302758-snap-lays-off-18-recruiters-hiring-slows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap lays off 18 recruiters as hiring slows</a></h4><ul>   <li>Snap (<a href=\"http://seekingalpha.com/symbol/SNAP\" target=\"_blank\">SNAP</a> <font color='green'>+2%</font>) has <a href=\"http://www.businessinsider.com/snap-hit-more-layoffs-plans-to-slow-hiring-in-2018-2017-10\" target=\"_blank\">laid off 18</a> in its recruiting division, a harbinger of a hiring slowdown at the social media/camera company.</li>    <li>An email from CEO Evan Spiegel to staffers that Business Insider saw in part said hiring would go slower in 2018 as leaders made \"hard decisions\" about the teams and performance.</li>    <li>The company's headcount has grown from about 600 employees at 2015's end to 2,600 last quarter.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302758\" data-linked=\"Snap lays off 18 recruiters as hiring slows\" data-tweet=\"$SNAP - Snap lays off 18 recruiters as hiring slows https://seekingalpha.com/news/3302758-snap-lays-off-18-recruiters-hiring-slows?source=tweet\" data-url=\"https://seekingalpha.com/news/3302758-snap-lays-off-18-recruiters-hiring-slows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>76&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302754\" data-ts=\"1508533808\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DBVT\" target=\"_blank\">DBVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302754-dbv-techs-viaskin-peanut-flunks-pivotal-study-shares-down-59-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DBV Tech&#39;s Viaskin Peanut flunks pivotal study; shares down 59% after hours</a></h4><ul><li>Thinly traded DBV Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies'>DBVT</a>) slumps&nbsp;<font color='red'>59%</font>&nbsp;after hours on increased volume in response to the <a href=\"http://www.nasdaq.com/article/dbv-technologies-peanut-allergy-drug-fails-key-study-20171020-00904\" target=\"_blank\">news </a>that its skin patch peanut allergy treatment, Viaskin Peanut, failed to demonstrate sufficient efficacy in a pivotal study as determined by a certain tolerance to peanut protein.</li><li>The company is undeterred, saying the study showed a statistically significant response with a favorable tolerability profile. It plans to file a U.S. marketing application in 2018.</li><li>Viaskin Peanut delivers peanut protein to patients' immune systems through the skin which desensitizes them to small doses of the allergen over time.</li><li>Rival Aimmune Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AIMT' title='Aimmune Therapeutics'>AIMT</a>) is up&nbsp;<font color='green'>27%</font>&nbsp;after hours. Its lead candidate is <a href=\"http://www.aimmune.com/clinical-trials/ar101-for-peanut-allergy/\" target=\"_blank\">AR101</a>, an oral therapy for peanut allergy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302754\" data-linked=\"DBV Tech&#39;s Viaskin Peanut flunks pivotal study; shares down 59% after hours\" data-tweet=\"$DBVT $DBVT $AIMT - DBV Tech&#39;s Viaskin Peanut flunks pivotal study; shares down 59% after hours https://seekingalpha.com/news/3302754-dbv-techs-viaskin-peanut-flunks-pivotal-study-shares-down-59-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3302754-dbv-techs-viaskin-peanut-flunks-pivotal-study-shares-down-59-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302750\" data-ts=\"1508532823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302750-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/XHB' title='SPDR Homebuilders ETF'>XHB</a> <font color='green'>+2.2%</font>. <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='green'>+2.0%</font>. <a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a> <font color='green'>+1.9%</font>. <a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a> <font color='green'>+1.8%</font>. <a href='https://seekingalpha.com/symbol/IYH' title='iShares U.S. Healthcare ETF'>IYH</a> <font color='green'>+1.7%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='red'>-4.4%</font>. <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a> <font color='red'>-3.9%</font>. <a href='https://seekingalpha.com/symbol/AMJ' title='JPMorgan Alerian MLP Index ETN'>AMJ</a> <font color='red'>-3.0%</font>. <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a> <font color='red'>-3.0%</font>. <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a> <font color='red'>-2.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302750\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$XHB $XLF $DIA - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3302750-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3302750-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302741\" data-ts=\"1508531784\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302741-fda-oks-expanded-uses-for-j-and-js-simponi-aria\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs expanded uses for J&amp;J&#39;s Simponi Aria</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/16975311-janssen-receives-two-u-s-fda-approvals-simponi-aria-golimumab-treatment-adults-active\" target=\"_blank\">approves </a>Johnson &amp; Johnson (NYSE:<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>) unit Janssen Biotech's SIMPONI ARIA (golimumab) for the treatment of adults with active psoriatic arthritis or active ankylosing spondylitis.</li><li>The product was first approved in the U.S. in July 2013 for rheumatoid arthritis.</li><li><a href=\"https://www.simponiaria.com/\" target=\"_blank\">SIMPONI ARIA</a> is a fully human anti-tumor necrosis factor therapy administered via 30-minute infusion.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302741\" data-linked=\"FDA OKs expanded uses for J&amp;J&#39;s Simponi Aria\" data-tweet=\"$JNJ - FDA OKs expanded uses for J&amp;J&#39;s Simponi Aria https://seekingalpha.com/news/3302741-fda-oks-expanded-uses-for-j-and-js-simponi-aria?source=tweet\" data-url=\"https://seekingalpha.com/news/3302741-fda-oks-expanded-uses-for-j-and-js-simponi-aria\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302735\" data-ts=\"1508530157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302735-report-sprint-comcast-settle-phone-patent-dispute\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Sprint, Comcast settle phone patent dispute</a></h4><ul>   <li>While the key story for Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) investors is <a href=\"https://seekingalpha.com/news/3302487-bloomberg-sprint-t-mobile-merger-announcement-heading-weeks-delay\" target=\"_blank\">whether or not (and when)</a> the company will pull off a merger announcement with T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>), the company has apparently settled its legal differences with Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+0.9%</font>) over a multi-year patent fight regarding digital phones.</li>    <li>A motion to dismiss was filed in a Sprint case against Comcast set to come to trial in Kansas Oct. 30, Bloomberg notes, while dismissal notices were also filed in Washington of Comcast cases against Sprint.</li>    <li>Terms weren't disclosed, but in SEC filings Comcast said Sprint had been seeking up to $950M.</li>    <li>Sprint wrapped up the day <font color='red'>down 2%</font> and T-Mobile <font color='red'>down 1.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302735\" data-linked=\"Report: Sprint, Comcast settle phone patent dispute\" data-tweet=\"$S $S $TMUS - Report: Sprint, Comcast settle phone patent dispute https://seekingalpha.com/news/3302735-report-sprint-comcast-settle-phone-patent-dispute?source=tweet\" data-url=\"https://seekingalpha.com/news/3302735-report-sprint-comcast-settle-phone-patent-dispute\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302731\" data-ts=\"1508529577\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGD\" target=\"_blank\">NGD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302731-new-golds-rainy-river-mine-starts-commercial-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Gold&#39;s Rainy River mine starts commercial production</a></h4><ul>     <li>New Gold (<a href='https://seekingalpha.com/symbol/NGD' title='New Gold Inc'>NGD</a> <font color='green'>+2.2%</font>)&nbsp;is higher after reporting that its Rainy River gold mine in Ontario has achieved <a href=\"https://seekingalpha.com/pr/16974551-new-gold-achieves-commercial-production-rainy-river-mine\" target=\"_blank\">first commercial production</a> for the first time, two weeks ahead of schedule.</li>     <li>NGD says Rainy River began processing ore in September, as scheduled, and announced its first gold pour earlier this month; in the first 30 days of operation, NGD the mine has successfully processed ~460K metric tons of ore.</li><li>NGD defines commercial production as exceeding 60% of nameplate capacity  over a 30-day period, and the Rainy River processing rate averaged 19K metric tons/day, or 90% of nameplate capacity, during the first 18 days of October.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302731\" data-linked=\"New Gold&#39;s Rainy River mine starts commercial production\" data-tweet=\"$NGD - New Gold&#39;s Rainy River mine starts commercial production https://seekingalpha.com/news/3302731-new-golds-rainy-river-mine-starts-commercial-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3302731-new-golds-rainy-river-mine-starts-commercial-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302730\" data-ts=\"1508528627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCCO\" target=\"_blank\">SCCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302730-southern-copper-hopes-for-tia-maria-permit-q1-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Southern Copper hopes for Tia Maria permit by Q1 2018</a></h4><ul>     <li>Southern Copper (<a href='https://seekingalpha.com/symbol/SCCO' title='Southern Copper Corporation'>SCCO</a> <font color='red'>-0.2%</font>) is little changed despite reporting better than expected <a href=\"https://seekingalpha.com/news/3302660-southern-copper-and-nbsp-beats-0_04-revenue-line\" target=\"_blank\">Q3 earnings</a> that doubled from a year ago as <a href=\"https://www.reuters.com/article/us-southern-copper-results/southern-copper-says-third-quarter-profit-doubled-expects-tia-maria-permit-idUSKBN1CP1S2\" target=\"_blank\">sales surged on higher copper prices</a>.</li>     <li>SCCO also says it expects Peru's government to issue a construction permit for its stalled $1.4B Tia Maria project in next year's Q1; SCCO suspended Tia Maria in 2015 following deadly protests by farmers worried about environmental impacts but says support for the project has since grown.</li>     <li>SCCO also expects the expansion at its Toquepala mine in Peru to wrap up in Q2 2018, potentially adding 100K tons/year to production; Tia Maria is forecast to produce 120K tons/year of copper.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302730\" data-linked=\"Southern Copper hopes for Tia Maria permit by Q1 2018\" data-tweet=\"$SCCO - Southern Copper hopes for Tia Maria permit by Q1 2018 https://seekingalpha.com/news/3302730-southern-copper-hopes-for-tia-maria-permit-q1-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3302730-southern-copper-hopes-for-tia-maria-permit-q1-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302727\" data-ts=\"1508526935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REDU\" target=\"_blank\">REDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302727-rise-education-strong-in-ipo-open\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rise Education strong in IPO open</a></h4><ul><li>Rise Education (NASDAQ:<a href='https://seekingalpha.com/symbol/REDU' title='RISE Education Cayman Ltd'>REDU</a>) trades&nbsp;<font color='green'>14% above</font>&nbsp;the $16 mark where the IPO was priced earlier today.</li><li>Shares hit their high mark at $17.86.</li><li>The Chinese provider of after-school English lessons is backed by Bain Capital.</li><li><a href=\"https://www.sec.gov/Archives/edgar/data/1712178/000119312517313697/d414107df1a.htm\" target=\"_blank\">SEC Form F-1</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3302727\" data-linked=\"Rise Education strong in IPO open\" data-tweet=\"$REDU - Rise Education strong in IPO open https://seekingalpha.com/news/3302727-rise-education-strong-in-ipo-open?source=tweet\" data-url=\"https://seekingalpha.com/news/3302727-rise-education-strong-in-ipo-open\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302667\" data-ts=\"1508526242\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGX\" target=\"_blank\">DGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302667-labcorp-and-waters-attractive-tax-reform-plays-wells-fargo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LabCorp and Waters attractive tax reform plays - Wells Fargo</a></h4><ul><li>In a note, Wells Fargo's Tim Evans says Republicans' tax reform plans bode well for companies in the life sciences tools and healthcare services arenas. Lowering the tax rate would be the most valuable change, followed by repatriation and capex deductions. He especially likes LabCorp and Waters.</li><li>Companies to watch:</li><li>Services: Quest Diagnostics (<a href='https://seekingalpha.com/symbol/DGX' title='Quest Diagnostics Incorporated'>DGX</a> <font color='green'>+1.7%</font>), LabCorp (<a href='https://seekingalpha.com/symbol/LH' title='Laboratory Corporation of America Holdings'>LH</a> <font color='green'>+0.1%</font>), West Pharmaceutical Services (<a href='https://seekingalpha.com/symbol/WST' title='West Pharmaceutical Services Inc.'>WST</a> <font color='green'>+0.3%</font>), Catalent (<a href='https://seekingalpha.com/symbol/CTLT' title='Catalent'>CTLT</a> <font color='red'>-0.2%</font>).</li><li>Life sciences gear: Waters (<a href='https://seekingalpha.com/symbol/WAT' title='Waters Corporation'>WAT</a> <font color='green'>+1.5%</font>), PerkinElmer (<a href='https://seekingalpha.com/symbol/PKI' title='PerkinElmer, Inc.'>PKI</a> <font color='green'>+0.4%</font>), Thermo Fisher Scientific (<a href='https://seekingalpha.com/symbol/TMO' title='Thermo Fisher Scientific Inc.'>TMO</a> <font color='green'>+0.7%</font>), Mettler Toledo (<a href='https://seekingalpha.com/symbol/MTD' title='Mettler Toledo International Inc.'>MTD</a> <font color='green'>+1.2%</font>), Bio-Rad (<a href='https://seekingalpha.com/symbol/BIO' title='Bio-Rad Laboratories, Inc.'>BIO</a> <font color='green'>+1.3%</font>), Bio-Techne (<a href='https://seekingalpha.com/symbol/TECH' title='Bio-Techne Corp.'>TECH</a>).</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3302667\" data-linked=\"LabCorp and Waters attractive tax reform plays - Wells Fargo\" data-tweet=\"$DGX $DGX $LH - LabCorp and Waters attractive tax reform plays - Wells Fargo https://seekingalpha.com/news/3302667-labcorp-and-waters-attractive-tax-reform-plays-wells-fargo?source=tweet\" data-url=\"https://seekingalpha.com/news/3302667-labcorp-and-waters-attractive-tax-reform-plays-wells-fargo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302722\" data-ts=\"1508525725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302722-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian'>TEAM</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/TISA' title='Top Image Systems, Ltd.'>TISA</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NCR' title='NCR Corporation'>NCR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/OPNT' title='Opiant Pharmaceuticals, Inc.'>OPNT</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SYNC' title='Synacor'>SYNC</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302722\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$TEAM $DGLY $TISA - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3302722-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3302722-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302718\" data-ts=\"1508525141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302718-firb-approves-of-cbs-purchase-of-australias-ten-network\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FIRB approves of CBS purchase of Australia&#39;s Ten Network</a></h4><ul>   <li>Australia's Foreign Investment Review Board has <a href=\"http://www.afr.com/business/media-and-marketing/tv/foreign-investment-review-board-approves-cbs-purchase-of-network-ten-20171020-gz5c0g\" target=\"_blank\">signed off</a> on the purchase of Ten Network by CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='green'>+2.3%</font>), <i>Australia Financial Review</i> reports.</li>    <li>Ten's creditors last month <a href=\"https://seekingalpha.com/news/3296202-creditors-vote-cbss-ten-bid\" target=\"_blank\">approved of the takeover</a>.</li>    <li>The FIRB approval is unsurprising but clears another hurdle for CBS, set to prevail over a rival bid from Bruce Gordon and Lachlan Murdoch.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3292391-australian-minister-ok-cbs-takeover-ten-network\" target=\"_blank\">Australian minister OK with CBS takeover of Ten Network</a> (Aug. 29 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302718\" data-linked=\"FIRB approves of CBS purchase of Australia&#39;s Ten Network\" data-tweet=\"$CBS $VIAC - FIRB approves of CBS purchase of Australia&#39;s Ten Network https://seekingalpha.com/news/3302718-firb-approves-of-cbs-purchase-of-australias-ten-network?source=tweet\" data-url=\"https://seekingalpha.com/news/3302718-firb-approves-of-cbs-purchase-of-australias-ten-network\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302716\" data-ts=\"1508524799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TUSK\" target=\"_blank\">TUSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302716-mammoth-energyplus-16-on-puerto-rico-power-restoration-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mammoth Energy +16% on Puerto Rico power restoration contract</a></h4><ul>     <li>Mammoth Energy Services (<a href='https://seekingalpha.com/symbol/TUSK' title='Mammoth Energy Services'>TUSK</a> <font color='green'>+16.1%</font>) surges following news that its Cobra Acquisitions subsidiary was hired to assist with <a href=\"https://seekingalpha.com/pr/16974653-mammoth-energy-announces-cobra-subsidiary-entered-contract-aid-rebuilding-puerto-rico-s\" target=\"_blank\">restoring electric power in Puerto Rico</a> following Hurricane Maria.</li>     <li>TUSK says the contract will begin immediately and is expected to generate revenue of up to $200M over the initial 120 days.</li>     <li>TUSK is expected to conduct comprehensive damage assessment of the existing electrical grid as well as providing engineering and construction services to rebuild the grid.</li>     <li>Imperial Capital raises its price target for TUSK shares to $24 from $20 after the Cobra contract award.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302716\" data-linked=\"Mammoth Energy +16% on Puerto Rico power restoration contract\" data-tweet=\"$TUSK - Mammoth Energy +16% on Puerto Rico power restoration contract https://seekingalpha.com/news/3302716-mammoth-energyplus-16-on-puerto-rico-power-restoration-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3302716-mammoth-energyplus-16-on-puerto-rico-power-restoration-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302712\" data-ts=\"1508523323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302712-financials-top-5-gainers-losers-of-2-15-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 2:15 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/INBK' title='First Internet Bancorp'>INBK</a> <font color='green'>+9%</font>.<a href='https://seekingalpha.com/symbol/COBZ' title='CoBiz Financial Inc.'>COBZ</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings'>YIN</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/OZM' title='Och-Ziff Capital Management Group LLC'>OZM</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AMNB' title='American National Bankshares, Inc.'>AMNB</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LHO' title='LaSalle Hotel Properties'>LHO</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/IBKC' title='IBERIABANK Corporation'>IBKC</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/BOCH' title='Bank of Commerce Holdings &#40;CA&#41;'>BOCH</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/GOV-OLD' title='Government Properties Income Trust'>GOV-OLD</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302712\" data-linked=\"Financials - Top 5 Gainers / Losers as of 2:15 PM\" data-tweet=\"$JP $INBK $COBZ - Financials - Top 5 Gainers / Losers as of 2:15 PM https://seekingalpha.com/news/3302712-financials-top-5-gainers-losers-of-2-15-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3302712-financials-top-5-gainers-losers-of-2-15-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302711\" data-ts=\"1508523072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302711-s-and-p-maintains-rating-on-windstream-amid-debt-exchange-sharesplus-3_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">S&amp;P maintains rating on Windstream amid debt exchange; shares +3.7%</a></h4><ul>   <li>S&amp;P has maintained its ratings on Windstream Holdings (<a href=\"http://seekingalpha.com/symbol/WIN\" target=\"_blank\">WIN</a> <font color='green'>+3.7%</font>) even after yesterday's <a href=\"https://seekingalpha.com/news/3302218-windstream-announces-debt-exchange-several-series\" target=\"_blank\">announcement of a debt exchange offer</a> (and amid a claim of default by bondholder Aurelius Capital).</li>    <li>&ldquo;We do not believe Windstream would default in the near- to medium-term if the proposed offers were not accepted,\" the firm says, noting that a successful exchange would stretch out maturities and cut refinancing risk in the medium term.</li>    <li>&ldquo;Investors would not be materially disadvantaged as a result of the exchanges based on the redemption premiums, or in certain cases, increased coupons with added security in exchange for extending maturities,\" S&amp;P adds. (h/t Bloomberg)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302711\" data-linked=\"S&amp;P maintains rating on Windstream amid debt exchange; shares +3.7%\" data-tweet=\"$WIN $WINMQ - S&amp;P maintains rating on Windstream amid debt exchange; shares +3.7% https://seekingalpha.com/news/3302711-s-and-p-maintains-rating-on-windstream-amid-debt-exchange-sharesplus-3_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3302711-s-and-p-maintains-rating-on-windstream-amid-debt-exchange-sharesplus-3_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302704\" data-ts=\"1508521526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302704-ge-goes-green\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE goes green</a></h4><ul><li><font color='red'>Down more than 6%</font>&nbsp;earlier following a Q3 earnings miss, and a big cut in guidance, General Electric (NYSE:<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a>) has moved&nbsp;<font color='green'>modestly into the green</font>&nbsp;on the session.</li><li>This just in: Markets anticipate, and GE was&nbsp;<font color='red'>down 25%</font>&nbsp;for the year prior to this morning's clunker. Also just in: New CEOs like to \"kitchen sink\" their initial earnings reports so as to make the numbers following implementation of their \"turnaround\" plans look that much better.</li><li>The move in GE has boosted the Dow (<a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a> <font color='green'>+0.6%</font>) in a big way, with that average now higher by 150 points.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302691-ge-cut-dividend-weak-q3-results-analysts-say\" target=\"_blank\">GE should cut dividend after weak Q3 results, analysts say</a> (Oct. 20)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302643-flannery-must-cut-ge-dividend-now-political-capital-degan-says\" target=\"_blank\">Flannery must cut GE dividend now while he has 'political capital,' DeGan says</a> (Oct. 20)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302534-general-electric-eps-0_29\" target=\"_blank\">General Electric EPS of $0.29</a> (Oct. 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302704\" data-linked=\"GE goes green\" data-tweet=\"$GE $GE $DIA - GE goes green https://seekingalpha.com/news/3302704-ge-goes-green?source=tweet\" data-url=\"https://seekingalpha.com/news/3302704-ge-goes-green\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302695\" data-ts=\"1508519116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302695-celgene-selloff-weighs-on-biotechs-ibb-down-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene selloff weighs on biotechs, IBB down 1%</a></h4><ul><li>Celgene's (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-10%</font>) mongersen-stoked selloff has engulfed its fellow biotechs.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a> <font color='red'>-1.1%</font>)(<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a> <font color='green'>+0.1%</font>)(<a href='https://seekingalpha.com/symbol/FBT' title='First Trust NYSE Arca Biotechnology Index ETF'>FBT</a> <font color='red'>-0.5%</font>)(<a href='https://seekingalpha.com/symbol/BBH' title='VanEck Vectors Biotech ETF'>BBH</a> <font color='red'>-1.2%</font>)(<a href='https://seekingalpha.com/symbol/BIB' title='ProShares Ultra Nasdaq Biotechnology ETF'>BIB</a> <font color='red'>-2.3%</font>)(<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='red'>-2.2%</font>)(<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color='red'>-1.1%</font>)(<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color='red'>-1%</font>)(<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color='red'>-1%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302442-celgene-hits-bump-road-ibd-candidate-gedminus-0301-two-studies-terminated-shares-poised-move\" target=\"_blank\">Celgene hits bump in road with IBD candidate GED-0301, two studies terminated; shares poised for down move after hours</a> (Oct. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302695\" data-linked=\"Celgene selloff weighs on biotechs, IBB down 1%\" data-tweet=\"$CELG $CELG $IBB - Celgene selloff weighs on biotechs, IBB down 1% https://seekingalpha.com/news/3302695-celgene-selloff-weighs-on-biotechs-ibb-down-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3302695-celgene-selloff-weighs-on-biotechs-ibb-down-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302692\" data-ts=\"1508517945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAN\" target=\"_blank\">MAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302692-manpowergroup-rallies-to-all-time-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ManpowerGroup rallies to all-time high</a></h4><ul> <li>ManpowerGroup(NYSE:<a href='https://seekingalpha.com/symbol/MAN' title='ManpowerGroup Inc.'>MAN</a>) powers to an all-time high of $124.24 after the company's Q3 results top estimates.</li> <li>The company said stronger foreign currencies helped it to a 7% increase in revenue during the quarter (+4% ex-F/X).</li> <li>\"We expect the broad-based global improvement in both employer hiring intentions and economic growth to provide us with good opportunities for continued profitable growth,\" says CEO Jonas Prising.</li> <li>Q4 EPS guidance is set at $2.01 to $2.09 vs. $2.00 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302562-manpower-beats-0_07-beats-revenue\" target=\"_blank\">Manpower beats by $0.07, beats on revenue</a> (Oct. 20)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3302692\" data-linked=\"ManpowerGroup rallies to all-time high\" data-tweet=\"$MAN - ManpowerGroup rallies to all-time high https://seekingalpha.com/news/3302692-manpowergroup-rallies-to-all-time-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3302692-manpowergroup-rallies-to-all-time-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302691\" data-ts=\"1508517598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302691-ge-should-cut-dividend-after-weak-q3-results-analysts-say\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE should cut dividend after weak Q3 results, analysts say</a></h4><ul>     <li>General Electric&rsquo;s (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-1.1%</font>) weak Q3 results and substantial cut to earnings  expectations (<a href=\"https://seekingalpha.com/news/3302559-first-ge-profit-miss-2_5-years\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/news/3302670-ge-ceo-flannery-says-cash-flow-horrible-new-normal\" target=\"_blank\">II</a>) indicate the \"<a href=\"https://www.streetinsider.com/Analyst+Comments/Morgan+Stanley+On+General+Electric+%28GE%29+Dividend%3A+%22the+correct+action+would+be+to+cut%22/13408135.html\" target=\"_blank\">correct action</a>\" would be lowering the  dividend, says Morgan Stanley analyst Nigel Coe.</li>     <li>Deutsche Bank's John Inch says GE \"falls well short\" of generating enough cash to pay its $8B common dividend from operations, which suggests that a  \"sizable dividend cut is pending,\" and the stock at 22x P/E now looks \"that much more expensive\"; the firm rates GE a Sell rating with a $21 price target.</li>     <li>A dividend cut is increasingly likely, and weak results look to continue  in Q4 with ongoing challenges in GE's power and oil and gas divisions,  says Stifel's Robert McCarthy.</li>     <li>Melius Research's Scott Davis reiterates a Buy rating and $35 price target on the stock, but says he is \"<a href=\"http://www.barrons.com/articles/ge-earnings-unacceptableand-thats-from-management-1508510908\" target=\"_blank\">downright angry</a> at retired CEO Jeff Immelt and the GE Board. They bled this company and harmed its brand over 16 years. If it&rsquo;s even remotely true that Immelt had a spare airplane following him around 'just in case,' [it] should be investigated as corporate theft with remuneration made back to shareholders. Let&rsquo;s hope it&rsquo;s not.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302691\" data-linked=\"GE should cut dividend after weak Q3 results, analysts say\" data-tweet=\"$GE - GE should cut dividend after weak Q3 results, analysts say https://seekingalpha.com/news/3302691-ge-should-cut-dividend-after-weak-q3-results-analysts-say?source=tweet\" data-url=\"https://seekingalpha.com/news/3302691-ge-should-cut-dividend-after-weak-q3-results-analysts-say\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302690\" data-ts=\"1508517588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302690-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='green'>+37%</font>. <a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian'>TEAM</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/TUSK' title='Mammoth Energy Services'>TUSK</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CAI' title='CAI International, Inc.'>CAI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/KALV' title='KalVista Pharmaceticals, Inc.'>KALV</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a> <font color='red'>-61%</font>. <a href='https://seekingalpha.com/symbol/TACO' title='Del Taco Restaurants, Inc.'>TACO</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NCR' title='NCR Corporation'>NCR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/KLDX' title='Klondex Mines Ltd.'>KLDX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/GNMX' title='Aevi Genomic Medicine, Inc.'>GNMX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302690\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SKX $QURE $TEAM - Midday Gainers / Losers https://seekingalpha.com/news/3302690-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3302690-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302688\" data-ts=\"1508517305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHL\" target=\"_blank\">CHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302688-china-mobileplus-2-revenues-rise-despite-rate-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Mobile +2% as revenues rise despite rate cuts</a></h4><ul>    <li>China Mobile (NYSE:<a href='https://seekingalpha.com/symbol/CHL' title='China Mobile Limited'>CHL</a>) is <font color='green'>up 2%</font> in U.S. trading after posting <a href=\"https://seekingalpha.com/news/3302580-china-mobile-reports-9m-results\" target=\"_blank\">earnings results</a> where nine-month profits rose 4.6% on revenues that grew nearly 5%.</li>    <li>Telecom services data rose 7.1% Y/Y to 515.3B yuan ($77.8B), despite a mandated rate cut for the company and its two state-owned peers in September.</li>    <li>Profits for the nine months hit 92.1B yuan ($13.9B).</li>    <li>Total customers reached 878M, up from last quarter's 867M; average revenue per user per month fell to 60.5 yuan from 62.2 last quarter.</li>    <li>Handset data traffic, meanwhile, blew up to 8,151.3B MB, up 69% from the total as of June 30 (4,830.9B MB).</li>    <li>In its wireline business, total customers came to 103.42M (it was 93.04M as of June 30), and average revenue per user per month climbed to 35.1 yuan from June 30's 34.9 yuan.</li>    <li><a href=\"http://www.chinamobileltd.com/en/file/view.php?id=182718\" target=\"_blank\">Press Release</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3302688\" data-linked=\"China Mobile +2% as revenues rise despite rate cuts\" data-tweet=\"$CHL - China Mobile +2% as revenues rise despite rate cuts https://seekingalpha.com/news/3302688-china-mobileplus-2-revenues-rise-despite-rate-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3302688-china-mobileplus-2-revenues-rise-despite-rate-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302687\" data-ts=\"1508517103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEAM\" target=\"_blank\">TEAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302687-atlassian-q1-beats-strong-guidance-and-pushed-over-10b-market-cap\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atlassian Q1: beats, strong guidance, and pushed over a $10B market cap</a></h4><ul><li>        Atlassian (NASDAQ:<a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian'>TEAM</a>) shares are up % following yesterday&rsquo;s <a href=\"https://seekingalpha.com/pr/16974378-atlassian-announces-first-quarter-fiscal-year-2018-results\" target=\"_blank\">Q1 report</a> featured EPS and revenue beats, Q2 guidance that beat consensus, and raised FY18 estimates.</li><li>               Q2 guidance: revenue, $203M to $205M (consensus: $200.23M); Non-IFRS gross margin, 84%; Non-IFRS operating margin, 19%; EPS, $0.12 (consensus: $0.10).&nbsp;</li><li>               FY18 guidance: revenue, $841M to $847M (consensus: $831.02M); Non-IFRS gross margin, 84%; Non-IFRS operating margin, 19%; EPS, $0.46 to $0.47 (consensus: $0.44); FCF, $250M to $260M; capital expenditures, $25M to $30M.&nbsp;</li><li>               Atlassian shares are&nbsp;<font color='green'>up 22.26%</font>, which pushed the company over the $10B market cap line for the first time since its IPO in December 2015.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3302687\" data-linked=\"Atlassian Q1: beats, strong guidance, and pushed over a $10B market cap\" data-tweet=\"$TEAM - Atlassian Q1: beats, strong guidance, and pushed over a $10B market cap https://seekingalpha.com/news/3302687-atlassian-q1-beats-strong-guidance-and-pushed-over-10b-market-cap?source=tweet\" data-url=\"https://seekingalpha.com/news/3302687-atlassian-q1-beats-strong-guidance-and-pushed-over-10b-market-cap\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302686\" data-ts=\"1508516717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COST\" target=\"_blank\">COST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302686-oppenheimer-positive-on-costco\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer positive on Costco</a></h4><ul> <li>Costco (NASDAQ:<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a>) is back over $160 with a <font color='green'>1.29% gain</font> on a solid day for the retail sector in general.</li> <li>The retailer is also on the <a href=\"http://www.barrons.com/articles/costco-5-reasons-to-load-up-1508509127\" target=\"_blank\">radar</a> of the analyst team at Oppenheimer after they met with Costco management.</li> <li>\"Management indicates clearly that the company is pleased with results lately and views strengthening sales as a function of a culmination of factors, including new merchandising initiatives and price investments,\" reads the Oppy note.</li> <li>Costco's new e-commerce delivery programs are also highlighted as a potential driver of sales and membership additions.</li> <li>Oppenheimer summary: \"Overall, we view recent concerns of Internet disintermediation at COST as overblown. We stick with our Outperform rating on COST shares.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302686\" data-linked=\"Oppenheimer positive on Costco\" data-tweet=\"$COST - Oppenheimer positive on Costco https://seekingalpha.com/news/3302686-oppenheimer-positive-on-costco?source=tweet\" data-url=\"https://seekingalpha.com/news/3302686-oppenheimer-positive-on-costco\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302685\" data-ts=\"1508516439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COF\" target=\"_blank\">COF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302685-synchrony-financial-leads-credit-card-names-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synchrony Financial leads credit card names higher</a></h4><ul><li>Synchrony Financial earlier topped Q3 estimates, and more importantly, showed <a href=\"https://seekingalpha.com/news/3302587-synchrony-financial-3-percent-solid-credit-metrics-q3\" target=\"_blank\">benign credit trends, with</a> charge-offs and provisions both lower than in Q2. Its shares are&nbsp;<font color='green'>higher by 4.85%</font>.</li><li>The financial sector (<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='green'>+1.1%</font>) overall is having a good day as the passage of tax cuts this year took a big step forward <a href=\"https://seekingalpha.com/news/3302642-treasury-bear-move-enters-new-territory\" target=\"_blank\">and interest rates take</a> a new leg higher, but credit cards are outperforming. In addition to Synchrony, CapOne (<a href='https://seekingalpha.com/symbol/COF' title='Capital One Financial Corporation'>COF</a> <font color='green'>+1.8%</font>), Discover (<a href='https://seekingalpha.com/symbol/DFS' title='Discover Financial Services'>DFS</a> <font color='green'>+2.1%</font>), and Alliance Data (<a href='https://seekingalpha.com/symbol/ADS' title='Alliance Data Systems Corporation'>ADS</a> <font color='green'>+3%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3302685\" data-linked=\"Synchrony Financial leads credit card names higher\" data-tweet=\"$COF $XLF $COF - Synchrony Financial leads credit card names higher https://seekingalpha.com/news/3302685-synchrony-financial-leads-credit-card-names-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3302685-synchrony-financial-leads-credit-card-names-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302680\" data-ts=\"1508515333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REGN\" target=\"_blank\">REGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302680-too-high-expectations-for-dupixent-in-asthma-reason-for-regeneron-downgrade-barclays-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Too-high expectations for Dupixent in asthma reason for Regeneron downgrade - Barclays; shares down 2%</a></h4><ul><li>Barclays says its downgrade of Regeneron Pharmaceuticals (<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color='red'>-1.5%</font>) to Underweight with a $395 (9% downside risk) price target was based on more modest expectations for Dupixent (dupilumab) in asthma than Street forecasts.</li><li>It cites its recent physician survey that indicated treatment rates in the moderate-to-severe population would remain modest and will unlikely grow to support sell-siders' views. Also, the asthma market is competitive, making it difficult for Dupixent to capture more than a limited market share.</li><li>Adding to Barclays' bearish outlook is the saturation of Eylea's AMD market.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3302680\" data-linked=\"Too-high expectations for Dupixent in asthma reason for Regeneron downgrade - Barclays; shares down 2%\" data-tweet=\"$REGN - Too-high expectations for Dupixent in asthma reason for Regeneron downgrade - Barclays; shares down 2% https://seekingalpha.com/news/3302680-too-high-expectations-for-dupixent-in-asthma-reason-for-regeneron-downgrade-barclays-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3302680-too-high-expectations-for-dupixent-in-asthma-reason-for-regeneron-downgrade-barclays-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302681\" data-ts=\"1508515312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302681-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/CROX' title='Crocs, Inc.'>CROX</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a> <font color='green'>+8%</font>. SCSS <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc. Class C'>UA</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/FLXS' title='Flexsteel Industries, Inc.'>FLXS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WILC' title='G. Willi-Food International, Ltd.'>WILC</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302681\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SKX $CROX $FUV - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3302681-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3302681-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302675\" data-ts=\"1508514705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPE\" target=\"_blank\">HPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302675-ubs-downgrades-hewlett-packard-enterprise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS downgrades Hewlett Packard Enterprise</a></h4><ul><li>        UBS <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171020111957HPE\" target=\"_blank\">downgrades</a> Hewlett Packard Enterprise (NYSE:<a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise'>HPE</a>) from Buy to Neutral and drops the price target by a dollar to $15.</li><li>               The downgrade comes as HPE neared the original price target.</li><li>               UBS also has concerns the company&rsquo;s streamlining plans could become disruptive, don&rsquo;t differentiate enough from the competition, and don&rsquo;t account for the fast than expected market growth for the public cloud.&nbsp;</li><li>               HPE shares are&nbsp;<font color='green'>up 1.73%</font>.&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3302675\" data-linked=\"UBS downgrades Hewlett Packard Enterprise\" data-tweet=\"$HPE - UBS downgrades Hewlett Packard Enterprise https://seekingalpha.com/news/3302675-ubs-downgrades-hewlett-packard-enterprise?source=tweet\" data-url=\"https://seekingalpha.com/news/3302675-ubs-downgrades-hewlett-packard-enterprise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302673\" data-ts=\"1508514405\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302673-bitcoin-nears-6k\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin nears $6K</a></h4><ul><li><font color='green'>Up more than 5%</font>&nbsp;today, bitcoin is at a new record and shy of $6K by just a few dollars, <a href=\"https://www.coindesk.com/quiet-surge-bitcoin-price-sets-new-high-just-6000/?utm_content=buffer6d0ee&amp;utm_medium=social&amp;utm_source=twitter.com&amp;utm_campaign=buffer\" target=\"_blank\">according to CoinDesk</a>. Other exchanges are currently pricing the cryptocurrency at more than $6K.</li><li>ZeroHedge notes that <a href=\"http://www.zerohedge.com/news/2017-10-20/zimbabwe-panic-sends-bitcoin-soaring-over-6000-now-bigger-goldman-sachs\" target=\"_blank\">now at near $100B in market cap</a>, cryptocurrencies are bigger than Goldman Sachs and Morgan Stanley.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, BIOP, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/UBIA' title='UBI BlockChain Internet Ltd.'>OTC:UBIA</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, PRELF, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3302673\" data-linked=\"Bitcoin nears $6K\" data-tweet=\"$GBTC $GBTC $COIN - Bitcoin nears $6K https://seekingalpha.com/news/3302673-bitcoin-nears-6k?source=tweet\" data-url=\"https://seekingalpha.com/news/3302673-bitcoin-nears-6k\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>158&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302672\" data-ts=\"1508514291\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBDSF\" target=\"_blank\">IBDSF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302672-reuters-iberdrola-concerned-siemens-management-of-wind-power-jv\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Iberdrola concerned about Siemens management of wind power JV</a></h4><ul>     <li>Spanish utility Iberdrola (<a href='https://seekingalpha.com/symbol/IBDSF' title='Iberdrola S.A.'>OTCPK:IBDSF</a>, <a href='https://seekingalpha.com/symbol/IBDRY' title='Iberdrola S.A. ADR'>OTCPK:IBDRY</a>) is growing <a href=\"http://www.reuters.com/article/us-siemensgamesa-management-exclusive/exclusive-iberdrola-demands-change-at-siemens-gamesa-as-problems-mount-idUSKBN1CP1TO\" target=\"_blank\">increasingly concerned</a> about how Siemens (<a href='https://seekingalpha.com/symbol/SIEGY' title='Siemens AG ADR'>OTCPK:SIEGY</a> <font color='red'>-2%</font>) is managing the Siemens Gamesa (<a href='https://seekingalpha.com/symbol/GCTAF' title='Siemens Gamesa Renewable Energy'>OTCPK:GCTAF</a>, <a href='https://seekingalpha.com/symbol/GCTAY' title='Siemens Gamesa Renewable Energy ADR'>OTCPK:GCTAY</a>) wind power joint venture, Reuters reports.</li>     <li>Alarmed by a second profit warning last week, Iberdrola called for significant changes at the top of Siemens Gamesa during a board meeting today, and the JV reportedly is set to announce a <a href=\"http://www.reuters.com/article/us-siemensgamesa-management-reshuffle/siemens-gamesa-announces-board-reshuffle-as-problems-mount-idUSKBN1CP1XI?il=0\" target=\"_blank\">major board reshuffle</a>.</li><li>Siemens has a controlling 59% stake in Siemens Gamesa; Iberdrola is the second largest shareholder with an 8% holding.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302672\" data-linked=\"Reuters: Iberdrola concerned about Siemens management of wind power JV\" data-tweet=\"$IBDSF $IBDSF $IBDRY - Reuters: Iberdrola concerned about Siemens management of wind power JV https://seekingalpha.com/news/3302672-reuters-iberdrola-concerned-siemens-management-of-wind-power-jv?source=tweet\" data-url=\"https://seekingalpha.com/news/3302672-reuters-iberdrola-concerned-siemens-management-of-wind-power-jv\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302671\" data-ts=\"1508514227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSYS\" target=\"_blank\">SSYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302671-susquehanna-upgrades-stratasys-sees-m-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna upgrades Stratasys, sees it as M&amp;A target</a></h4><ul><li>        Susquehanna Financial Group <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10205148/the-stratasys-bull-case-includes-2018-strength-buyout-p\" target=\"_blank\">upgrades</a> Stratasys (NASDAQ:<a href='https://seekingalpha.com/symbol/SSYS' title='Stratasys, Inc.'>SSYS</a>) from Neutral to Positive and ups its price target from $22 to $31.</li><li>               Analyst David Ryzhik thinks Stratasys can return to revenue growth next year due to a new product and general stabilization in the MarketBot business.&nbsp;</li><li>               Ryzhik sees EPS upside and the potential for M&amp;A as the company has an increasing recurring revenue stream and a broad product and property portfolio.&nbsp;</li><li>               Stratasys shares are&nbsp;<font color='green'>up 8.21%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3302671\" data-linked=\"Susquehanna upgrades Stratasys, sees it as M&amp;A target\" data-tweet=\"$SSYS - Susquehanna upgrades Stratasys, sees it as M&amp;A target https://seekingalpha.com/news/3302671-susquehanna-upgrades-stratasys-sees-m-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3302671-susquehanna-upgrades-stratasys-sees-m-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302670\" data-ts=\"1508513535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302670-ge-ceo-flannery-says-cash-flow-horrible-not-new-normal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE CEO Flannery says cash flow &quot;horrible&quot; but &quot;not the new normal&quot;</a></h4><ul>     <li>Perhaps the biggest shock from GE's (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-2.4%</font>) \"<a href=\"http://www.barrons.com/articles/ge-earnings-unacceptableand-thats-from-management-1508510908\" target=\"_blank\">unacceptable</a>\" <a href=\"https://seekingalpha.com/news/3302559-first-ge-profit-miss-2_5-years\" target=\"_blank\">Q3 results</a> is the new projection for $7B in cash flow from operating activities, a steep drop from the company's previous view of $12B-$14B.</li>     <li>Cash flow for 2017 is \"horrible,\" CEO&nbsp;John Flannery tells CNBC, but it's \"<a href=\"https://www.cnbc.com/2017/10/20/ge-ceo-john-flannery-says-everything-is-up-for-review.html\" target=\"_blank\">not the new normal </a>- $7B is not the new normal. There are a  number of steps we are going to take significantly in 2018.\"</li>     <li>The drop in cash flow has raised persistent questions about how GE will fund its dividend, pensions and capital investments; while current cash flow projections may not become the norm, Flannery says GE is looking to balance investing in growth and paying the dividend, adding that investors should think of 2018 as a &ldquo;<a href=\"https://www.wsj.com/articles/ge-earnings-fall-as-new-leadership-picks-up-restructuring-work-1508497764\" target=\"_blank\">reset year</a>.&rdquo;</li>     <li>Q3 operating cash flow was $1.7B,&nbsp;excluding deal taxes and pension plan funding; GE&rsquo;s liquidity came under scrutiny after the company reported negative $1.6B in industrial operating cash flow in Q1, then rebounding modestly in Q2.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302670\" data-linked=\"GE CEO Flannery says cash flow &quot;horrible&quot; but &quot;not the new normal&quot;\" data-tweet=\"$GE - GE CEO Flannery says cash flow &quot;horrible&quot; but &quot;not the new normal&quot; https://seekingalpha.com/news/3302670-ge-ceo-flannery-says-cash-flow-horrible-not-new-normal?source=tweet\" data-url=\"https://seekingalpha.com/news/3302670-ge-ceo-flannery-says-cash-flow-horrible-not-new-normal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>62&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302668\" data-ts=\"1508513212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRCO\" target=\"_blank\">TRCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302668-sinclair-broadcast-nexstar-gain-deutsche-bank-starts-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinclair Broadcast, Nexstar gain as Deutsche Bank starts at Buy</a></h4><ul>   <li>Sinclair Broadcast Group (<a href=\"http://seekingalpha.com/symbol/SBGI\" target=\"_blank\">SBGI</a> <font color='green'>+2.2%</font>) and Nexstar Media Group (<a href=\"http://seekingalpha.com/symbol/NXST\" target=\"_blank\">NXST</a> <font color='green'>+1.6%</font>) are higher today after Deutsche Bank started both companies at Buy, pointing to opportunities in valuations depressed by investor worries about media firms.</li>    <li>DB also has a new Hold rating on Tribune Media (NYSE:<a href='https://seekingalpha.com/symbol/TRCO' title='Tribune Media Company'>TRCO</a>), currently <a href=\"https://seekingalpha.com/news/3302303-tribune-media-shareholders-approve-3_9b-sinclair-buyout\" target=\"_blank\">under pursuit by Sinclair</a> in a $3.9B buyout bid.</li>    <li>Speaking of the two broadcast groups, the firm argues that there's more stability in retransmission revenue than thought.</li>    <li>Sinclair in particular is about 30% below its 52-week high, and <a href=\"https://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Starts+Sinclair+Broadcasting+%28SBGI%29+at+Buy/13406853.html\" target=\"_blank\">fears around runaway reverse compensation</a> and possible affiliation loss are overdone, writes Clay Griffin.</li>    <li>Risk/reward are fine as a stand-alone firm, but \"the benefits of scale PF with Tribune -- including a more effective presence in the national advertising markets, stepping TRCO retrans rates onto SBGI's more favorable rate card, and operational cost synergies -- are also very attractive.\"</li>    <li>Deutsche Bank has a price target of $46 on Sinclair (implying 49% upside) and $80 on Nexstar (implying 31% upside).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302668\" data-linked=\"Sinclair Broadcast, Nexstar gain as Deutsche Bank starts at Buy\" data-tweet=\"$TRCO $TRCO $SBGI - Sinclair Broadcast, Nexstar gain as Deutsche Bank starts at Buy https://seekingalpha.com/news/3302668-sinclair-broadcast-nexstar-gain-deutsche-bank-starts-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3302668-sinclair-broadcast-nexstar-gain-deutsche-bank-starts-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302665\" data-ts=\"1508512389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNTX\" target=\"_blank\">GNTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302665-on-gentexs-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Gentex&#39;s Q3</a></h4><ul><li>Gentex (<a href='https://seekingalpha.com/symbol/GNTX' title='Gentex Corporation'>GNTX</a> <font color='red'>-5.1%</font>)&nbsp;reports Automotive net sales rose 2% to $428.2M in <a href=\"https://seekingalpha.com/pr/16974829-gentex-reports-third-quarter-2017-financial-results\" target=\"_blank\">Q3</a>, due to 5% rise in auto-dimming mirror unit shipments sequentially.</li><li>Total auto-dimming mirror units +500 Y/Y to 9,613.</li><li>Gross margin rate down 150 bps to 39%.</li><li>Operating margin rate squeezed 180 bps to 29.4%.</li><li><b>FY2017 Guidance</b>: Net sales: $1.78B to $1.80B; Gross margin rate: 38.5% to 39%; Operating expense: $165M to $170M; Tax rate: 31% to 32%; Capex: $110M to $120M; D&amp;A: $95M to $100M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302665\" data-linked=\"More on Gentex&#39;s Q3\" data-tweet=\"$GNTX - More on Gentex&#39;s Q3 https://seekingalpha.com/news/3302665-on-gentexs-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3302665-on-gentexs-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302663\" data-ts=\"1508512101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISRG\" target=\"_blank\">ISRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302663-intuitive-up-4-after-q3-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuitive up 4% after Q3 earnings</a></h4><ul><li>Intuitive Surgical (<a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a> <font color='green'>+3.9%</font>) reverses course after a brief selloff after it reported Q3 results yesterday after the close. Shares were down almost&nbsp;<font color='red'>3%</font>&nbsp;before recovering.</li><li>Bullish analysts have weighed in to support the stock:</li><li>Morgan Stanley (Overweight/$390): Some \"controversy\" around management commentary on 2018 margins, but is \"comfortable\" that company can maintain/expand its leadership in robotic surgery.</li><li>Leerink (Outperform/$390): Investors \"should be fine\" with company's strategy.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302411-intuitive-surgical-q3-revenue-7-percent-earnings-34-percent-shares-4-percent-hours\" target=\"_blank\">Intuitive Surgical Q3 revenue up 7%; earnings up 34%; shares up 4% after hours</a> (Oct. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302663\" data-linked=\"Intuitive up 4% after Q3 earnings\" data-tweet=\"$ISRG - Intuitive up 4% after Q3 earnings https://seekingalpha.com/news/3302663-intuitive-up-4-after-q3-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3302663-intuitive-up-4-after-q3-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302662\" data-ts=\"1508511707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302662-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='green'>+10%</font>. NEOT <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology'>MYOS</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a> <font color='red'>-59%</font>. <a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/GNMX' title='Aevi Genomic Medicine, Inc.'>GNMX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302662\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$QURE $ACRX $EVFM - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3302662-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3302662-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302661\" data-ts=\"1508511667\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMX\" target=\"_blank\">AMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302661-america-movilplus-2-credit-suisse-boosts-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">America Movil +2% as Credit Suisse boosts to Outperform</a></h4><ul>     <li>America Movil (NYSE:<a href='https://seekingalpha.com/symbol/AMX' title='America Movil SA de CV'>AMX</a>) is <font color='green'>up 2%</font> in the wake of a boost to Outperform at Credit Suisse, which sees higher profitability coming from reduced regulatory risk in Mexico.</li>     <li>Changes coming in 2018 from Mexico's telecom regulator will boost the mobile termination rate that America Movil receives from rivals, and cut the rate that it pays to them, with an 1.5-point impact to America Movil's EBITDA margin in the country.</li>     <li>Cost controls should also improve margins, and volatility in foreign exchange rates makes the company a safer option than domestic calls, writes analyst Daniel Federle, noting that just 30% of its EBITDA comes from Mexico.</li>     <li>He boosted his price target to $21 from $19, implying 10.4% upside from today's higher price.</li>     <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302661\" data-linked=\"America Movil +2% as Credit Suisse boosts to Outperform\" data-tweet=\"$AMX - America Movil +2% as Credit Suisse boosts to Outperform https://seekingalpha.com/news/3302661-america-movilplus-2-credit-suisse-boosts-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3302661-america-movilplus-2-credit-suisse-boosts-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302657\" data-ts=\"1508511294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302657-cleveland-cliffsminus-5-after-cutting-full-year-iron-ore-sales-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleveland-Cliffs -5% after cutting full-year iron ore sales outlook</a></h4><ul>     <li>Cleveland-Cliffs (<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='red'>-5.1%</font>) plunges after beating <a href=\"https://seekingalpha.com/news/3302582-cleveland-cliffs-beats-0_04-beats-revenue\" target=\"_blank\">Q3 earnings</a> and revenue estimates but cutting its full-year sales and production volume outlook for its U.S. Iron Ore and Asia Pacific segment by 500K tons, mainly due to ore quality.</li>     <li>CLF cuts its U.S. iron ore outlook cut to 18.5M tons from 19M due to significant reduction in pellet nomination by a large customer; for 2018, CLF sees sales and production volumes of 20M tons, due to increased capacity from the acquisition of the remaining minority  interest in the Tilden mine.</li>     <li>CLF also chops its Asia Pacific sales outlook to 10.5M metric tons and production to 11M, citing operational decisions reflecting current market conditions  and quality ore availability; for 2018, it expects Asia Pacific iron ore sales and production volumes of 11M metric tons.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302657\" data-linked=\"Cleveland-Cliffs -5% after cutting full-year iron ore sales outlook\" data-tweet=\"$CLF - Cleveland-Cliffs -5% after cutting full-year iron ore sales outlook https://seekingalpha.com/news/3302657-cleveland-cliffsminus-5-after-cutting-full-year-iron-ore-sales-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3302657-cleveland-cliffsminus-5-after-cutting-full-year-iron-ore-sales-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302655\" data-ts=\"1508511147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBNY\" target=\"_blank\">SBNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302655-signature-bank-rises-for-second-day-post-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Signature Bank rises for second day post-earnings</a></h4><ul><li>Bears may be reassessing after the bank Thursday morning <a href=\"https://seekingalpha.com/news/3302070-signature-bank-beats-0_10-misses-revenue\" target=\"_blank\">topped Q3 estimates </a>by a mile.</li><li>On the sidelines prior, BMO's Lana Chan upgrades to Outperform, noting the near-all-time low valuation and significant discount to peers the stock is trading at (shares are&nbsp;<font color='red'>down 12%</font>&nbsp;YTD).</li><li>Management, she says, \"appears open to selling,\" which should limit downside risk to the $7B market cap bank.</li><li>Her price target of $145 suggests about&nbsp;<font color='green'>10% upside</font>&nbsp;from the current level.</li><li>Source: Bloomberg</li><li><a href='https://seekingalpha.com/symbol/SBNY' title='Signature Bank'>SBNY</a>&nbsp;<font color='green'>+4.5%</font>&nbsp;to $131.76</li></ul><div class=\"tiny-share-widget\" data-id=\"3302655\" data-linked=\"Signature Bank rises for second day post-earnings\" data-tweet=\"$SBNY - Signature Bank rises for second day post-earnings https://seekingalpha.com/news/3302655-signature-bank-rises-for-second-day-post-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3302655-signature-bank-rises-for-second-day-post-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302652\" data-ts=\"1508510738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXRX-OLD\" target=\"_blank\">CXRX-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302652-debt-laden-pharmas-under-pressure-on-concordias-debt-restructuring\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Debt-laden pharmas under pressure on Concordia&#39;s debt restructuring</a></h4><ul><li>Pharma investors are heading for the exits after Concordia International (<a href='https://seekingalpha.com/symbol/CXRX-OLD' title='Concordia International Corp'>CXRX-OLD</a> <font color='red'>-30%</font>) announced its debt restructuring under Canadian law.</li><li>Other high-debt-burden drug makers: Shire plc (<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='red'>-1.4%</font>), Endo International (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='red'>-1.6%</font>), Mallinckrodt (<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt PLC'>MNK</a> <font color='red'>-2.1%</font>), Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-0.4%</font>) and Valeant Pharmaceuticals (VRX <font color='red'>-2.5%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302637-concordia-use-court-proceeding-restructure-debt-trading-resume-shortly\" target=\"_blank\">Concordia to use court proceeding to restructure debt; trading to resume shortly</a> (Oct. 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302652\" data-linked=\"Debt-laden pharmas under pressure on Concordia&#39;s debt restructuring\" data-tweet=\"$CXRX-OLD $CXRX-OLD $SHPG - Debt-laden pharmas under pressure on Concordia&#39;s debt restructuring https://seekingalpha.com/news/3302652-debt-laden-pharmas-under-pressure-on-concordias-debt-restructuring?source=tweet\" data-url=\"https://seekingalpha.com/news/3302652-debt-laden-pharmas-under-pressure-on-concordias-debt-restructuring\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>60&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302650\" data-ts=\"1508510384\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHGE\" target=\"_blank\">BHGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302650-baker-hughes-schlumberger-slide-following-caution-on-oil-services-demand\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baker Hughes, Schlumberger slide following caution on oil services demand</a></h4><ul>     <li>Baker Hughes (<a href='https://seekingalpha.com/symbol/BHGE' title='Baker Hughes, a GE company'>BHGE</a> <font color='red'>-2.6%</font>) and Schlumberger (<a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color='red'>-3.5%</font>) turn sharply lower following <a href=\"http://www.reuters.com/article/us-schlumberger-results/schlumberger-baker-hughes-warn-of-north-america-slowdown-idUSKBN1CP1D9\" target=\"_blank\">cautionary comments</a> from both oil services firms of a challenging year ahead.</li>     <li>Echoing a <a href=\"https://seekingalpha.com/news/3302597-schlumberger-edges-higher-line-quarter\" target=\"_blank\">similar warning</a> from SLB earlier today, and CEO&nbsp;Lorenzo Simonelli says \"We expect the overall oil and gas environment to remain challenging for  the rest of the year. We have seen some improvement  in activity, but we have not seen meaningful increases in customer capital commitments. Oil prices remain volatile and, as a result, our customers remain cautious.\"</li>     <li>In its initial quarter under the General Electric umbrella, BHGE's <a href=\"https://seekingalpha.com/news/3302549-baker-hughes-misses-0_07-misses-revenue\" target=\"_blank\">Q3 earnings</a> came in below expectations while revenues remained flat Y/Y.</li>     <li>Orders for the quarter were $5.72B, up 2% Q/Q and up 18% Y/Y; service orders rose 5% Q/Q but fell 11% Y/Y, while equipment orders fell 1% Q/Q and rose 32% Y/Y.</li>     <li>Backlog at the end of Q3 grew 1% Q/Q to $20.9B, with equipment backlog +3% to $5.7B and services backlog +1% to $15.2B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302650\" data-linked=\"Baker Hughes, Schlumberger slide following caution on oil services demand\" data-tweet=\"$BHGE $BKR $SLB - Baker Hughes, Schlumberger slide following caution on oil services demand https://seekingalpha.com/news/3302650-baker-hughes-schlumberger-slide-following-caution-on-oil-services-demand?source=tweet\" data-url=\"https://seekingalpha.com/news/3302650-baker-hughes-schlumberger-slide-following-caution-on-oil-services-demand\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302649\" data-ts=\"1508509961\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSRGY\" target=\"_blank\">NSRGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302649-third-point-confident-nestle-investment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Third Point confident with Nestle investment</a></h4><ul> <li>Third Point discloses in its letter to investors that it has invested about $3.5B in Nestle (<a href='https://seekingalpha.com/symbol/NSRGY' title='Nestle S.A. ADR'>OTCPK:NSRGY</a>, <a href='https://seekingalpha.com/symbol/NSRGF' title='Nestle S.A.'>OTCPK:NSRGF</a>) this year.</li> <li>Dan Loeb and team indicate that they are pleased with the direction of Nestle's management and expect double-digit EPS growth through 2020.</li> <li>\"There is much more opportunity to unlock value, particularly by further optimizing capital allocation and carefully evaluating the L&rsquo;Oreal stake as part of a comprehensive portfolio review,\" writes Third Point.</li> <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302649\" data-linked=\"Third Point confident with Nestle investment\" data-tweet=\"$NSRGY $NSRGY $NSRGF - Third Point confident with Nestle investment https://seekingalpha.com/news/3302649-third-point-confident-nestle-investment?source=tweet\" data-url=\"https://seekingalpha.com/news/3302649-third-point-confident-nestle-investment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302646\" data-ts=\"1508509846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302646-analyst-weigh-in-on-celgenes-flop-in-crohns-mongersen-shares-down-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst weigh in on Celgene&#39;s flop in Crohn&#39;s with mongersen; shares down 10%</a></h4><ul><li>Sell-side analysts comment on Celgene's (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-10.3%</font>) decision to stop development of GED-0301 (mongersen):</li><li>Baird: Price target cut to $136 from $162. Pressure for pipeline to pay off increasing, especially considering eventual generic competition to top seller Revlimid. MS/Crohn's/UC candidate ozanimod has to be a winner.</li><li>RBC: Price target cut to $166 from $173&nbsp; puts more pressure on ozanimod to be the major growth driver despite GED-0301 always being considered high risk. The amount of the stock's down move seems appropriate.</li><li>Mizuho: Selloff myopic since ozanimod is also being developed for Crohn's. Would be buyers here.</li><li>Oppenheimer: Price target cut to $170 from $175.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3302646\" data-linked=\"Analyst weigh in on Celgene&#39;s flop in Crohn&#39;s with mongersen; shares down 10%\" data-tweet=\"$CELG - Analyst weigh in on Celgene&#39;s flop in Crohn&#39;s with mongersen; shares down 10% https://seekingalpha.com/news/3302646-analyst-weigh-in-on-celgenes-flop-in-crohns-mongersen-shares-down-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3302646-analyst-weigh-in-on-celgenes-flop-in-crohns-mongersen-shares-down-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302648\" data-ts=\"1508509790\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSM\" target=\"_blank\">TSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302648-taiwan-semiconductor-orders-69_43m-in-equipment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taiwan Semiconductor orders $69.43M in equipment</a></h4><ul><li>        Taiwan Semiconductor Manufacturing Co. (NYSE:<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a>) <a href=\"http://www.reuters.com/article/brief-tsmc-orders-machinery-equipment-wo/brief-tsmc-orders-machinery-equipment-worth-t2-1-bln-idUSH9N1MR02O?feedType=RSS&amp;feedName=companyNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FcompanyNews+%28News+%2F+US+%2F+Company+News%29\" target=\"_blank\">says</a> it has ordered $69.43M in machinery.</li><li>               Lam Research (NASDAQ:<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>) and Applied Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>) were the machinery sources.&nbsp;</li><li>               TSMC shares are&nbsp;<font color='red'>down 0.51%.</font>&nbsp;</li><li>               Lam Research shares are&nbsp;<font color='green'>up 1.81%</font>.&nbsp;</li><li>               Applied Materials shares are&nbsp;<font color='green'>up 1.22%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302155-taiwan-semiconductor-reports-q3-guidance-beats\" target=\"_blank\">Taiwan Semiconductor reports Q3, guidance beats</a> (Oct. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302648\" data-linked=\"Taiwan Semiconductor orders $69.43M in equipment\" data-tweet=\"$TSM $TSM $LRCX - Taiwan Semiconductor orders $69.43M in equipment https://seekingalpha.com/news/3302648-taiwan-semiconductor-orders-69_43m-in-equipment?source=tweet\" data-url=\"https://seekingalpha.com/news/3302648-taiwan-semiconductor-orders-69_43m-in-equipment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302644\" data-ts=\"1508509372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVOTF\" target=\"_blank\">EVOTF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302644-evotec-short-pitch-robin-hood-conference-shares-fall-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evotec short pitch at Robin Hood conference; shares fall 4%</a></h4><ul><li>No details, but Lakewood Capital's Anthony Bozza is pitching German pharmaceutical player Evotec as a short at the Robin Hood conference.</li><li>Shares are&nbsp;<font color='red'>down 4.25%</font>&nbsp;in German action. The ADRs (<a href='https://seekingalpha.com/symbol/EVTCY' title='Evotec AG ADR'>OTCPK:EVTCY</a>) are&nbsp;<font color='red'>lower by 4.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302644\" data-linked=\"Evotec short pitch at Robin Hood conference; shares fall 4%\" data-tweet=\"$EVOTF $EVTCY - Evotec short pitch at Robin Hood conference; shares fall 4% https://seekingalpha.com/news/3302644-evotec-short-pitch-robin-hood-conference-shares-fall-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3302644-evotec-short-pitch-robin-hood-conference-shares-fall-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302643\" data-ts=\"1508508969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302643-flannery-must-cut-ge-dividend-now-while-political-capital-degan-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flannery must cut GE dividend now while he has &#39;political capital,&#39; DeGan says</a></h4><ul>     <li>New General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-2.8%</font>)&nbsp;Chairman and CEO&nbsp;John Flannery will never have more \"<a href=\"https://www.cnbc.com/2017/10/20/ge-shareholder-new-ceo-should-to-cut-the-massive-dividend.html\" target=\"_blank\">political capital</a>\" to cut the dividend than now, Harbor Advisory's Jack De Gan tells CNBC following the company's <a href=\"https://seekingalpha.com/news/3302559-first-ge-profit-miss-2_5-years\" target=\"_blank\">huge earnings miss</a>.</li>     <li>\"Clearly a dividend cut would free up a lot of flexibility for John Flannery to execute his restructuring; $8B a year in dividends is a big burden,\" De Gan tells Squawk Box. \"It would upset the shareholder base, and the stock would be dead money for while. [But] this is when he should do it.\"</li>     <li>At a price of ~$22.75/share and a current annual dividend of $0.96, GE's dividend yield is now 4.19%, its highest in 30 years not including the 2008 financial crisis.</li>     <li>In its earnings call, GE says a final decision on the dividend would be announced at its investors day meeting, scheduled for Nov. 13.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302643\" data-linked=\"Flannery must cut GE dividend now while he has &#39;political capital,&#39; DeGan says\" data-tweet=\"$GE - Flannery must cut GE dividend now while he has &#39;political capital,&#39; DeGan says https://seekingalpha.com/news/3302643-flannery-must-cut-ge-dividend-now-while-political-capital-degan-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3302643-flannery-must-cut-ge-dividend-now-while-political-capital-degan-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>55&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302642\" data-ts=\"1508508887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302642-treasury-bear-move-enters-new-territory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Treasury bear move enters new territory</a></h4><ul><li>Threatening to drop below 2% around Labor Day, the 10-year Treasury yield is up another six basis points today to 2.383%. This session's excuse for the selling was<a href=\"https://seekingalpha.com/news/3302500-first-steps-towards-tax-reform\" target=\"_blank\"> last night's passage</a> of a $4T budget measure, seemingly paving the way for the Trump tax cuts.</li><li>As sharp as the rise in yields has been over the past few weeks, the 10-year isn't yet threatening its 2017 high of nearly 2.60% (set in March).</li><li><a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a><font color='red'> -1.05%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='green'>+2.1%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3302642\" data-linked=\"Treasury bear move enters new territory\" data-tweet=\"$TLT $TBT - Treasury bear move enters new territory https://seekingalpha.com/news/3302642-treasury-bear-move-enters-new-territory?source=tweet\" data-url=\"https://seekingalpha.com/news/3302642-treasury-bear-move-enters-new-territory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302641\" data-ts=\"1508508808\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKX\" target=\"_blank\">SKX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302641-skechers-lights-torch-in-retail-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Skechers lights a torch in retail sector</a></h4><ul> <li>Shares of Skechers (NYSE:<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a>) are on a rocket ride after the company's earnings blasted right past estimates on the back of a 4.4% gain in comparable store sales.</li> <li>Many investment firm like Wedbush were caught off-guard. \"While we felt there was opportunity developing in the story looking to FY18, key drivers inflected sooner than we expected, particularly around international growth and gross margin, which were the largest contributors to the upside and our revised estimates,\" admits the <a href=\"http://www.marketwatch.com/story/skechers-upgraded-on-continued-growth-potential-around-the-world-2017-10-20\" target=\"_blank\">Wedbush analyst team</a>.</li> <li>During the Skechers conference call (<a href=\"https://seekingalpha.com/article/4114930-skechers-usa-skx-q3-2017-results-earnings-call-transcript?part=single\" target=\"_blank\">transcript</a>), management said that they expect the momentum to continue into 2018 as the international business continues to add to the bottom line.</li> <li>Skechers is&nbsp;<font color='green'>up 35%</font>&nbsp;on huge volume, and taking up a number of shoe and apparel stocks with it. Wolverine World Wide (<a href='https://seekingalpha.com/symbol/WWW' title='Wolverine World Wide Inc.'>WWW</a> <font color='green'>+3.7%</font>), Nike (<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color='green'>+1%</font>), Crocs (<a href='https://seekingalpha.com/symbol/CROX' title='Crocs, Inc.'>CROX</a> <font color='green'>+8%</font>), Steven Madden (<a href='https://seekingalpha.com/symbol/SHOO' title='Steven Madden, Ltd.'>SHOO</a> <font color='green'>+3.3%</font>), Perry Ellis (<a href='https://seekingalpha.com/symbol/PERY' title='Perry Ellis International Inc.'>PERY</a> <font color='green'>+4%</font>), Under Armour (<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a> <font color='green'>+4.2%</font>), Deckers Outdoor (<a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a> <font color='green'>+3.1%</font>), Caleres (<a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a> <font color='green'>+3.9%</font>), Columbia Sportswear (<a href='https://seekingalpha.com/symbol/COLM' title='Columbia Sportswear Company'>COLM</a> <font color='green'>+2.5%</font>), Finish Line (<a href='https://seekingalpha.com/symbol/FINL' title='The Finish Line, Inc.'>FINL</a> <font color='green'>+4.4%</font>), Shoe Carnival (<a href='https://seekingalpha.com/symbol/SCVL' title='Shoe Carnival, Inc.'>SCVL</a> <font color='green'>+2.9%</font>), Genesco (<a href='https://seekingalpha.com/symbol/GCO' title='Genesco Inc.'>GCO</a> <font color='green'>+6.5%</font>), Boot Barn (<a href='https://seekingalpha.com/symbol/BOOT' title='Boot Barn Holdings'>BOOT</a> <font color='green'>+2.2%</font>), Dick's Sporting Goods (<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a> <font color='green'>+3.2%</font>) and Hibbett Sports (<a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a> <font color='green'>+4.8%</font>) all have party hats on.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302353-skechers-beats-0_15-beats-revenue\" target=\"_blank\">Skechers beats by $0.15, beats on revenue</a> (Oct. 19)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302396-skechers-soars-jogging-past-profit-estimates\" target=\"_blank\">Skechers soars after jogging past profit estimates</a> (Oct. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302641\" data-linked=\"Skechers lights a torch in retail sector\" data-tweet=\"$SKX $SKX $WWW - Skechers lights a torch in retail sector https://seekingalpha.com/news/3302641-skechers-lights-torch-in-retail-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3302641-skechers-lights-torch-in-retail-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302639\" data-ts=\"1508508657\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DBD\" target=\"_blank\">DBD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302639-diebold-drops-after-ncr-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diebold drops after NCR earnings miss</a></h4><ul>     <li>Diebold Nixdorf (NYSE:<a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf'>DBD</a>) falls as much as&nbsp;<font color='red'>7%</font>&nbsp;after NCR <a href=\"https://seekingalpha.com/news/3302479-ncr-reports-q3-lowers-guidance-miss-estimates-shares-minus-10_93-percent\" target=\"_blank\">reported</a> Q4 results Thursday that trailed estimates and cut annual guidance due to disappointing ATM orders.</li>     <li>Credit Suisse analyst Paul Condra said yesterday NCR&rsquo;s ATM weakness would likely cause investors to take a cautious view on DBD, even though it&rsquo;s \"unclear to what extent this is incrementally negative for DBD.\"</li>     <li>NCR (NYSE:<a href='https://seekingalpha.com/symbol/NCR' title='NCR Corporation'>NCR</a>) shares are down as much as&nbsp;<font color='red'>15%</font>.</li>     <li>Also:&nbsp;<a href=\"https://seekingalpha.com/article/4114933-ncrs-ncr-ceo-bill-nuti-q3-2017-results-earnings-call-transcript\" target=\"_blank\">NCR's (<a href='https://seekingalpha.com/symbol/NCR' title='NCR Corporation'>NCR</a>) CEO Bill Nuti on Q3 2017 Results</a>, <a href=\"https://seekingalpha.com/article/4114895-ncr-corporation-2017-q3-results-earnings-call-slides\" target=\"_blank\">NCR's 2017 Q3 Results - Earnings Call Slides</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3302639\" data-linked=\"Diebold drops after NCR earnings miss\" data-tweet=\"$DBD $DBD $NCR - Diebold drops after NCR earnings miss https://seekingalpha.com/news/3302639-diebold-drops-after-ncr-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3302639-diebold-drops-after-ncr-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302637\" data-ts=\"1508508420\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXRX-OLD\" target=\"_blank\">CXRX-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302637-concordia-to-use-court-proceeding-to-restructure-debt-trading-to-resume-shortly\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Concordia to use court proceeding to restructure debt; trading to resume shortly</a></h4><ul><li>With the aim of realigning its capital structure, Concordia International (<a href='https://seekingalpha.com/symbol/CXRX-OLD' title='Concordia International Corp'>CXRX-OLD</a>) commences a <a href=\"https://seekingalpha.com/pr/16975004-concordia-international-corp-takes-next-step-realign-capital-structure-commencing-proceedings\" target=\"_blank\">court proceeding</a> under the Canada Business Corporations Act that will allow it to restructure its debt obligations.</li><li>Current management will continue to lead day-to-day operations and says the proceeding is not a bankruptcy or insolvency action.</li><li>Trading will resume at 10:15 am ET.</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>28%</font>&nbsp;after resumption of trading.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302637\" data-linked=\"Concordia to use court proceeding to restructure debt; trading to resume shortly\" data-tweet=\"$CXRX-OLD - Concordia to use court proceeding to restructure debt; trading to resume shortly https://seekingalpha.com/news/3302637-concordia-to-use-court-proceeding-to-restructure-debt-trading-to-resume-shortly?source=tweet\" data-url=\"https://seekingalpha.com/news/3302637-concordia-to-use-court-proceeding-to-restructure-debt-trading-to-resume-shortly\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302632\" data-ts=\"1508507873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EAPH\" target=\"_blank\">EAPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302632-easton-pharma-completes-jv-deal-for-half-interest-in-canadian-marijuana-farm-shares-up-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Easton Pharma completes JV deal for half interest in Canadian marijuana farm; shares up 9%</a></h4><ul><li>Easton Pharmaceuticals (<a href='https://seekingalpha.com/symbol/EAPH' title='Easton Pharmaceuticals, Inc.'>OTCPK:EAPH</a> <font color='green'>+8.6%</font>) has made the final <a href=\"https://seekingalpha.com/pr/16974841-easton-pharmaceuticals-announces-final-payment-completing-1_3-million-jv-agreement-alliance\" target=\"_blank\">payment </a>in its $1.3M (Canadian) JV agreement with Alliance Group for a 50% ownership interest in a range of businesses involved in the cultivation of recreational marijuana, including a 135-acre tract of land.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302632\" data-linked=\"Easton Pharma completes JV deal for half interest in Canadian marijuana farm; shares up 9%\" data-tweet=\"$EAPH - Easton Pharma completes JV deal for half interest in Canadian marijuana farm; shares up 9% https://seekingalpha.com/news/3302632-easton-pharma-completes-jv-deal-for-half-interest-in-canadian-marijuana-farm-shares-up-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3302632-easton-pharma-completes-jv-deal-for-half-interest-in-canadian-marijuana-farm-shares-up-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302629\" data-ts=\"1508507134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOJA\" target=\"_blank\">BOJA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302629-bojangles-crumbles-after-cowen-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bojangles crumbles after Cowen cut</a></h4><ul> <li>Cowen <a href=\"https://twitter.com/CowenResearch/status/921320929355030528\" target=\"_blank\">downgrades</a> Bojangles (NASDAQ:<a href='https://seekingalpha.com/symbol/BOJA' title='Bojangles&#39;'>BOJA</a>) to Market Perform from Outperform.</li> <li>The investment firm slashes its price target by 30% to lower it to $14 on a lack of confidence in a turnaround in sales, concerns over labor costs and an examination of 2018 unit openings.</li> <li>Shares of Bojangles are&nbsp;<font color='red'>already down 3.60%</font>&nbsp;in early trading and were within pennies of hitting their 52-week low.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302629\" data-linked=\"Bojangles crumbles after Cowen cut\" data-tweet=\"$BOJA - Bojangles crumbles after Cowen cut https://seekingalpha.com/news/3302629-bojangles-crumbles-after-cowen-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3302629-bojangles-crumbles-after-cowen-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302628\" data-ts=\"1508506936\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFTBF\" target=\"_blank\">SFTBF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302628-wsj-softbank-planning-200b-sequel-to-vision-fund\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: SoftBank planning $200B sequel to Vision Fund</a></h4><ul><li>           SoftBank&rsquo;s (<a href='https://seekingalpha.com/symbol/SFTBF' title='SoftBank Group'>OTCPK:SFTBF</a>, <a href='https://seekingalpha.com/symbol/SFTBY' title='SoftBank Group ADR'>OTCPK:SFTBY</a>) plans for the second version of its Vision Fund could total $200B, says a source for <a href=\"https://www.wsj.com/articles/japans-softbank-plans-a-second-giant-technology-fund-1508502097\" target=\"_blank\">The Wall Street Journal</a>. </li><li> The news follows SoftBank head Masayoshi Son&rsquo;s comments that he wants to launch a new fund very couple of years and invest in 1K companies within ten years. </li><li> The $200B fund is in its early stages so details could change.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3302493-nikkei-softbank-envisions-multiple-sequels-100b-vision-fund\" target=\"_blank\">Nikkei: SoftBank envisions multiple sequels to $100B Vision Fund</a> (Oct. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302628\" data-linked=\"WSJ: SoftBank planning $200B sequel to Vision Fund\" data-tweet=\"$SFTBF $SFTBF $SFTBY - WSJ: SoftBank planning $200B sequel to Vision Fund https://seekingalpha.com/news/3302628-wsj-softbank-planning-200b-sequel-to-vision-fund?source=tweet\" data-url=\"https://seekingalpha.com/news/3302628-wsj-softbank-planning-200b-sequel-to-vision-fund\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302627\" data-ts=\"1508506880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXRX-OLD\" target=\"_blank\">CXRX-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302627-trading-halted-in-concordia-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading halted in Concordia pending news</a></h4><ul><li>Nasdaq has <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">suspended trading</a> in Concordia International (<a href='https://seekingalpha.com/symbol/CXRX-OLD' title='Concordia International Corp'>CXRX-OLD</a>) pending the release of news.</li><li><strong>Update</strong>: Trading will resume at 10:15 am ET following its announcement of court proceeding allowing it to restructure debt.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302637-concordia-use-court-proceeding-restructure-debt-trading-resume-shortly\" target=\"_blank\">Concordia to use court proceeding to restructure debt; trading to resume shortly</a> (Oct. 20)</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>28%</font>&nbsp;on resumption of trading.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302627\" data-linked=\"Trading halted in Concordia pending news\" data-tweet=\"$CXRX-OLD - Trading halted in Concordia pending news https://seekingalpha.com/news/3302627-trading-halted-in-concordia-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3302627-trading-halted-in-concordia-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302623\" data-ts=\"1508506017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGM\" target=\"_blank\">MGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302623-goldman-sachs-full-of-conviction-on-mgm-resorts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs full of conviction on MGM Resorts</a></h4><ul> <li>Shares of MGM Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>) head higher in early trading after Goldman Sachs names the casino stock as a Conviction Buy List pick.</li> <li>The firm thinks the recent sell-off creates a significant long-term opportunity for investors and sets a one-year price target on MGM of $41 (35% upside). As far as Las Vegas, analyst Stephen Grambling reminds that the new NHL team and a booked convention calendar should help alleviate some concerns over a traffic dip.</li> <li>MGM <font color='green'>+1.84%</font> premarket to $31.04.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302623\" data-linked=\"Goldman Sachs full of conviction on MGM Resorts\" data-tweet=\"$MGM - Goldman Sachs full of conviction on MGM Resorts https://seekingalpha.com/news/3302623-goldman-sachs-full-of-conviction-on-mgm-resorts?source=tweet\" data-url=\"https://seekingalpha.com/news/3302623-goldman-sachs-full-of-conviction-on-mgm-resorts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302622\" data-ts=\"1508505907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302622-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a> <font color='red'>-57%</font>&nbsp;as pain med Posimir <a href=\"https://seekingalpha.com/news/3302613-durects-pain-med-posimir-flunks-late-stage-study-shares-plummet-55-percent-premarket\" target=\"_blank\">flunks</a> late-stage study.</li><li><a href='https://seekingalpha.com/symbol/NCR' title='NCR Corporation'>NCR</a> <font color='red'>-16%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3302368-ncr-beats-0_03-misses-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-8%</font>&nbsp;as it recorded pre-tax <a href=\"https://seekingalpha.com/news/3302552-celgene-record-pre-tax-charge-high-500m-q4-mongersen-stop-shares-5-percent-premarket\" target=\"_blank\">charge</a> as high as $500M in Q4 for mongersen stop.</li><li><a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-6%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3302534-general-electric-eps-0_29\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/AAXN' title='Axon Enterprise, Inc.'>AAXN</a> <font color='red'>-6%</font>&nbsp;continues <a href=\"https://seekingalpha.com/news/3302591-axon-continues-drop-sec-review\" target=\"_blank\">lower</a> on SEC review.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302622\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$DRRX $NCR $CELG - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3302622-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3302622-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302621\" data-ts=\"1508505833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERIC\" target=\"_blank\">ERIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302621-ericssonplus-8_1-q3-shows-sign-of-light-in-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ericsson +8.1% as Q3 shows sign of light in margins</a></h4><ul>   <li>Ericsson (NASDAQ:<a href='https://seekingalpha.com/symbol/ERIC' title='LM Ericsson Telephone Company'>ERIC</a>) is <font color='green'>up 8.1%</font> premarket after its <a href=\"https://seekingalpha.com/news/3302518-lm-ericsson-telephone-company-reports-q3-results\" target=\"_blank\">latest quarterly loss</a> showed glimmers that a turnaround was at hand.</li>    <li>Operating losses and net losses widened substantially, and revenues fell 6.5%, but margins improved in the company's core network business.</li>    <li>\"The general market conditions continue to be tough,\" CEO Borje Ekholm said in a statement.</li>    <li>While sales fell 6% on an as-reported basis, they declined 3% after adjusting for comparable units and currency. Network sales that fell 4% on a headline basis were up slightly after adjusting for units, currency and a rescoped North American managed services contract.</li>    <li>Gross margin was 25.4%; adjusted gross margin was 30% helped by the margin boost in Networks (11% in adjusted operating margin).</li>    <li>\"We remain fully committed to our focused business strategy,\" Ekholm says. \"We continue to invest to secure technology leadership and year to date we have recruited more than 1,000 R&amp;D employees in Networks. Customers give positive feedback on both our long-term strategy and on our current 5G-ready portfolio.\"</li>    <li><a href=\"https://seekingalpha.com/pr/16974693-ericsson-reports-third-quarter-results-2017\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3302621\" data-linked=\"Ericsson +8.1% as Q3 shows sign of light in margins\" data-tweet=\"$ERIC - Ericsson +8.1% as Q3 shows sign of light in margins https://seekingalpha.com/news/3302621-ericssonplus-8_1-q3-shows-sign-of-light-in-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3302621-ericssonplus-8_1-q3-shows-sign-of-light-in-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302619\" data-ts=\"1508505532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302619-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a> <font color='green'>+36%</font>&nbsp;<a href=\"https://seekingalpha.com/pr/16974774-digital-ally-vievu-llc-enter-supply-agreement\" target=\"_blank\">entered</a> into an exclusive supply agreement with VIEVU.</li><li><a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='green'>+29%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3302353-skechers-beats-0_15-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/ONVO' title='Organovo Holdings, Inc.'>ONVO</a> <font color='green'>+16%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16974859-organovo-presents-new-preclinical-data-3d-bioprinted-human-liver-tissues-treatment-inborn\" target=\"_blank\">new preclinical data</a> showing extended survival and sustained functionality of its 3D bioprinted human liver tissue when implanted into diseased animal models.</li><li><a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='green'>+10%</font>.</li><li><a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3302570-redhill-biopharma-10-percent-premarket-following-u-s-orphan-drug-tag-upamostat\" target=\"_blank\">following</a> U.S. Orphan Drug tag for upamostat.</li><li><a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='green'>+9%</font>.</li><li><a href='https://seekingalpha.com/symbol/ERIC' title='LM Ericsson Telephone Company'>ERIC</a> <font color='green'>+8%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3302518-lm-ericsson-telephone-company-reports-q3-results\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/PYPL' title='PayPal Holdings, Inc.'>PYPL</a> <font color='green'>+7%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3302362-paypal-beats-0_03-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/IMMY-OLD' title='Imprimis Pharmaceuticals, Inc.'>IMMY-OLD</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302619\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$DGLY $SKX $ONVO - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3302619-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3302619-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302620\" data-ts=\"1508505532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNTX\" target=\"_blank\">GNTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302620-genetx-and-auto-supplier-peers-on-watch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genetx and auto supplier peers on watch</a></h4><ul> <li>Light revenue turned in today by Gentex (NASDAQ:<a href='https://seekingalpha.com/symbol/GNTX' title='Gentex Corporation'>GNTX</a>) could impact the broad auto supplier sector. Gentex management cited a decline in North America light vehicle production and annual customer price reductions as negative factors during the quarter.</li> <li>Gentex also issued FY17 revenue guidance just a shade short of estimates, saying it expects sales of $1.78B to $1.80B vs. $1.81B consensus and $1.79B to $1.83B prior view.</li> <li>A couple of names to watch in the jittery auto supplier sector per Bloomberg are Genuine Parts (NYSE:<a href='https://seekingalpha.com/symbol/GPC' title='Genuine Parts Company'>GPC</a>), American Axle &amp; Manufacturing (NYSE:<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a>), Delphi Automotive (NYSE:<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a>) and Standard Motor Products (NYSE:<a href='https://seekingalpha.com/symbol/SMP' title='Standard Motor Products, Inc.'>SMP</a>).</li><li>Shares of Gentex are <font color='red'>down 6.82%</font> in premarket trading to $19.25. Gentex was up over 11% in the three months heading into the earnings print.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302579-gentex-eps-line-misses-revenue\" target=\"_blank\">Gentex EPS in-line, misses on revenue</a> (Oct. 20)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302620\" data-linked=\"Genetx and auto supplier peers on watch\" data-tweet=\"$GNTX $GNTX $GPC - Genetx and auto supplier peers on watch https://seekingalpha.com/news/3302620-genetx-and-auto-supplier-peers-on-watch?source=tweet\" data-url=\"https://seekingalpha.com/news/3302620-genetx-and-auto-supplier-peers-on-watch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302618\" data-ts=\"1508505258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302618-micron-technology-up-after-positive-tepper-comments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron Technology up after positive Tepper comments</a></h4><ul><li>        Micron Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) shares are&nbsp;<font color='green'>up 2.08%&nbsp;</font>premarket on positive comments from Appaloosa&rsquo;s David Tepper.</li><li>                  Tepper <a href=\"https://twitter.com/markflowchatter/status/921357952115728385\" target=\"_blank\">reportedly said</a> that Micron could double or triple from its current level.    </li><li>               Will update with more information when available. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3302618\" data-linked=\"Micron Technology up after positive Tepper comments\" data-tweet=\"$MU - Micron Technology up after positive Tepper comments https://seekingalpha.com/news/3302618-micron-technology-up-after-positive-tepper-comments?source=tweet\" data-url=\"https://seekingalpha.com/news/3302618-micron-technology-up-after-positive-tepper-comments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>112&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302615\" data-ts=\"1508504883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOV\" target=\"_blank\">DOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302615-doverplus-3-third-point-acquires-activist-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dover +3% as Third Point acquires activist stake</a></h4><ul>     <li>Dover (NYSE:<a href='https://seekingalpha.com/symbol/DOV' title='Dover Corp'>DOV</a>) <font color='green'>+2.9%</font> premarket on news that Daniel Loeb's Third Point hedge fund <a href=\"https://www.cnbc.com/2017/10/20/daniel-loebs-third-point-bought-industrial-dover-corp-in-third-quarter.html\" target=\"_blank\">bought a stake</a> in the company during Q3.</li><li>\"While Dover shares have started to appreciate since these  announcements, we still see significant upside with shares trading at  14x 2019 estimated free cash flow versus the broader multi-industrial  peer group that trades at 18x 2019 consensus free cash flow,\" according to a letter obtained by CNBC.</li>     <li>Third Point is said to be \"engaged in constructive dialogue\" with DOV and recommends separating the company's energy segment.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302615\" data-linked=\"Dover +3% as Third Point acquires activist stake\" data-tweet=\"$DOV - Dover +3% as Third Point acquires activist stake https://seekingalpha.com/news/3302615-doverplus-3-third-point-acquires-activist-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3302615-doverplus-3-third-point-acquires-activist-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302613\" data-ts=\"1508504804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRRX\" target=\"_blank\">DRRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302613-durects-pain-med-posimir-flunks-late-stage-study-shares-plummet-55-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DURECT&#39;s pain med Posimir flunks late-stage study; shares plummet 55% premarket</a></h4><ul><li>Durect (NASDAQ:<a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a>) craters&nbsp;<font color='red'>55%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16974615-durect-announces-top-line-results-persist-phase-3-trial-posimir-saber-bupivacaine-meet\" target=\"_blank\">announcement </a>that a Phase 3 clinical trial assessing POSIMIR (SABER-Bupivacaine) for the local treatment of postoperative pain failed to achieve its primary endpoint of reducing pain on movement over the first 48 hours after surgery compared to standard bupivacaine HCl.</li><li>POSIMIR is an extended-release formulation of bupivacaine designed to deliver the drug to the surgical site for 72 hours.</li><li>The company says it will more fully analyze the data over the coming weeks.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302613\" data-linked=\"DURECT&#39;s pain med Posimir flunks late-stage study; shares plummet 55% premarket\" data-tweet=\"$DRRX - DURECT&#39;s pain med Posimir flunks late-stage study; shares plummet 55% premarket https://seekingalpha.com/news/3302613-durects-pain-med-posimir-flunks-late-stage-study-shares-plummet-55-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3302613-durects-pain-med-posimir-flunks-late-stage-study-shares-plummet-55-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302610\" data-ts=\"1508504587\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302610-soft-economic-data-sends-loonie-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soft economic data sends loonie lower</a></h4><ul><li>Canadian <a href=\"https://www.statcan.gc.ca/daily-quotidien/171020/dq171020b-eng.htm?HPA=1\" target=\"_blank\">retail sales</a> fell 0.3% in August vs. estimates for a gain of 0.5%. Ex-food &amp; beverage, gasoline, and autos, sales fell 1.3%.</li><li>Meanwhile, <a href=\"https://www.statcan.gc.ca/daily-quotidien/171020/dq171020a-eng.htm?HPA=1\" target=\"_blank\">CPI rose</a> 1.6% Y/Y vs. estimates for 1.7%. Core CPI rose 1.8%.</li><li>The loonie (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a>) has&nbsp;<font color='red'>dipped&nbsp;</font>nearly three-quarters of a percent vs. the greenback, now buying $0.7954.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWC' title='iShares MSCI Canada ETF'>EWC</a>, <a href='https://seekingalpha.com/symbol/CNDA' title='IQ Canada Small Cap ETF'>CNDA</a>, <a href='https://seekingalpha.com/symbol/EWCS' title='iShares MSCI Canada Small Cap Index ETF'>EWCS</a>, <a href='https://seekingalpha.com/symbol/QCAN' title='SPDR MSCI Canada Quality Mix ETF'>QCAN</a>, <a href='https://seekingalpha.com/symbol/FCAN' title='First Trust Canada AlphaDex ETF'>FCAN</a>, <a href='https://seekingalpha.com/symbol/HEWC' title='iShares Currency Hedged MSCI Canada ETF'>HEWC</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3302610\" data-linked=\"Soft economic data sends loonie lower\" data-tweet=\"$FXC $EWC $CNDA - Soft economic data sends loonie lower https://seekingalpha.com/news/3302610-soft-economic-data-sends-loonie-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3302610-soft-economic-data-sends-loonie-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302607\" data-ts=\"1508504350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302607-rbc-capital-latest-to-slash-estimates-on-chipotle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC Capital the latest to slash estimates on Chipotle</a></h4><ul> <li>Another bruising price target cut arrives on Chipotle (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>) from Wall Street.</li> <li>Thisi time around it's RBC Capital warning on elevated labor costs and a disappointing impact from the queso introduction on the level of same-store sales.</li> <li>Analyst David Palmer lowers profit estimates Chipotle for 2017 through 2019 due to the lack of confidence. His new price target is $330, down from $400. Shares of Chipotle are <font color='green'>up 0.22%</font> to $326.00 in light premarket trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3301729-baml-warns-chipotles-labor-costs\" target=\"_blank\">BAML warns on Chipotle's labor costs</a> (Oct. 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302607\" data-linked=\"RBC Capital the latest to slash estimates on Chipotle\" data-tweet=\"$CMG - RBC Capital the latest to slash estimates on Chipotle https://seekingalpha.com/news/3302607-rbc-capital-latest-to-slash-estimates-on-chipotle?source=tweet\" data-url=\"https://seekingalpha.com/news/3302607-rbc-capital-latest-to-slash-estimates-on-chipotle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302540\" data-ts=\"1508504314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEMP\" target=\"_blank\">GEMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302540-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Gemphire Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a>) initiated with Buy rating and $30 (218% upside) price target by Roth Capital. Shares up&nbsp;<font color='green'>5%&nbsp;</font>premarket but only on 100 shares.</li><li>Madrigal Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a>) initiated with Buy rating and $62 (32% upside) by Roth.</li><li>Seattle Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a>) upgraded to Overweight with a $70 (9% upside) price target by Barclays. Shares up&nbsp;<font color='green'>2%</font>&nbsp;premarket on 210 shares.</li><li>UniQure (NASDAQ:<a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a>) price target raised to $19 (27% upside) from $17 by Leerink.</li><li>Regeneron Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a>) downgraded to Underweight by Barclays. Shares down&nbsp;<font color='red'>2%</font>&nbsp;premarket on light volume.</li><li>Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>) downgraded to Neutral with a $136 (flat) price target by Robert Baird after GED-0301 discontinuation. Downgraded to Neutral by Citigroup with a $140 price target. Shares down&nbsp;<font color='red'>7%</font>&nbsp;premarket on robust volume.</li><li>Durect (NASDAQ:<a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a>) downgraded to Hold by Stifel. Shares down&nbsp;<font color='red'>55%</font>&nbsp;premarket on robust volume on failed Phase 3 POSIMIR&nbsp;study.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3302540\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$GEMP $GEMP $MDGL - Premarket analyst action - healthcare https://seekingalpha.com/news/3302540-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3302540-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302604\" data-ts=\"1508503657\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENRJ\" target=\"_blank\">ENRJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302604-enerjex-resourcesplus-134-on-merger-deal-ageagle-aerial-systems\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EnerJex Resources +134% on merger deal with AgEagle Aerial Systems</a></h4><ul>     <li>EnerJax Resources (NYSEMKT:<a href='https://seekingalpha.com/symbol/ENRJ' title='Enerjex Resources, Inc.'>ENRJ</a>) <font color='green'>+134.3%</font> premarket after signing a <a href=\"https://globenewswire.com/news-release/2017/10/20/1150867/0/en/EnerJex-Resources-Signs-Definitive-Merger-Agreement-with-Commercial-Drone-Company-AgEagle-Aerial-Systems.html\" target=\"_blank\">merger agreement</a> with AgEagle Aerial Systems, an agricultural drone company.</li><li>ENRJ says its shareholders will own ~15% of the combined company upon completion of the deal.</li>     <li>ENRJ also says it received notice from the NYSE that it is not in compliance with continued listing standards relating to stockholders&rsquo; equity.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302604\" data-linked=\"EnerJex Resources +134% on merger deal with AgEagle Aerial Systems\" data-tweet=\"$ENRJ - EnerJex Resources +134% on merger deal with AgEagle Aerial Systems https://seekingalpha.com/news/3302604-enerjex-resourcesplus-134-on-merger-deal-ageagle-aerial-systems?source=tweet\" data-url=\"https://seekingalpha.com/news/3302604-enerjex-resourcesplus-134-on-merger-deal-ageagle-aerial-systems\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302602\" data-ts=\"1508503414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAPR\" target=\"_blank\">CAPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302602-capricor-down-9-premarket-on-expected-dilution-from-14m-stock-sales-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capricor down 9% premarket on expected dilution from $14M stock sales agreement</a></h4><ul><li>Capricor Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a>) is down&nbsp;<font color='red'>9%</font>&nbsp;premarket on light volume in apparent reaction to its $14M \"at-the-market\" common stock sales <a href=\"https://www.sec.gov/Archives/edgar/data/1133869/000114420417053253/tv477294_424b5.htm\" target=\"_blank\">agreement </a>with H.C. Wainwright.</li><li>Yesterday's close was $2.41 so $14M represents ~5.8M shares which will be ~25% dilution to the ~23.5M shares currently outstanding.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302602\" data-linked=\"Capricor down 9% premarket on expected dilution from $14M stock sales agreement\" data-tweet=\"$CAPR - Capricor down 9% premarket on expected dilution from $14M stock sales agreement https://seekingalpha.com/news/3302602-capricor-down-9-premarket-on-expected-dilution-from-14m-stock-sales-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3302602-capricor-down-9-premarket-on-expected-dilution-from-14m-stock-sales-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302598\" data-ts=\"1508502535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUPH\" target=\"_blank\">AUPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302598-aurinia-expands-pipeline-programs-for-voclosporin-shares-ahead-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurinia expands pipeline programs for voclosporin; shares ahead 2% premarket</a></h4><ul><li>At its <a href=\"https://seekingalpha.com/pr/16974811-aurinia-expand-renal-franchise-novel-indications-launches-development-program-treatment-dry\" target=\"_blank\">R&amp;D Day</a> today, Aurinia Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a>) will discuss the expansion of renal development programs for lead candidate voclosporin into focal segmental glomerulosclerosis and minimal change disease. A Phase 2 proof-of-concept study will launch in H1 2018.</li><li>In addition, the company plans to evaluate <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406237/\" target=\"_blank\">nanomicellar&nbsp;</a>voclosporin ophthalmic solution for the treatment of dry eye syndrome. A Phase 2a tolerability study will commence in Q2 2018.</li><li>Voclosporin is currently in Phase 3 development for lupus nephritis. Enrollment in the AURORA study should be completed in H2 2018 ahead of the start of its rolling NDA submission.</li><li>The webcast of the R&amp;D Day will start momentarily.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302598\" data-linked=\"Aurinia expands pipeline programs for voclosporin; shares ahead 2% premarket\" data-tweet=\"$AUPH - Aurinia expands pipeline programs for voclosporin; shares ahead 2% premarket https://seekingalpha.com/news/3302598-aurinia-expands-pipeline-programs-for-voclosporin-shares-ahead-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3302598-aurinia-expands-pipeline-programs-for-voclosporin-shares-ahead-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302591\" data-ts=\"1508501398\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAXN\" target=\"_blank\">AAXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302591-axon-continues-drop-on-sec-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axon continues drop on SEC review</a></h4><ul><li>\"New Disclosure Of SEC Scrutiny May Validate Our Prior Concerns,\" <a href=\"https://seekingalpha.com/article/4114996-axon-enterprise-new-disclosure-sec-scrutiny-may-validate-prior-concerns\" target=\"_blank\">writes</a> Aparecium Research in an article on Seeking Alpha.</li><li>\"We believe that Axon has overstated its underlying profitability and inflated its revenue growth through aggressive accounting, where future revenue and profits are pulled forward and associated costs are deferred far into the future.\"</li><li>Axon (NASDAQ:<a href='https://seekingalpha.com/symbol/AAXN' title='Axon Enterprise, Inc.'>AAXN</a>) is another leg lower this morning, <font color='red'>down 9.4%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302480-axon-says-sec-reviewing-financial-reports\" target=\"_blank\">Axon says SEC is reviewing its financial reports</a> (Oct. 19 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302591\" data-linked=\"Axon continues drop on SEC review\" data-tweet=\"$AAXN - Axon continues drop on SEC review https://seekingalpha.com/news/3302591-axon-continues-drop-on-sec-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3302591-axon-continues-drop-on-sec-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302583\" data-ts=\"1508501034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PG\" target=\"_blank\">PG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302583-light-profit-guidance-from-procter-gamble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Light profit guidance from Procter &amp; Gamble</a></h4><ul> <li>Procter &amp; Gamble (NYSE:<a href='https://seekingalpha.com/symbol/PG' title='The Procter & Gamble Company'>PG</a>) reports organic sales increased 1% in <a href=\"https://seekingalpha.com/pr/16974775-p-and-g-announces-first-quarter-earnings\" target=\"_blank\">FQ1</a>.</li> <li>Volume was up 1% during the quarter, led by a 2% gain in the fabric &amp; home care segment. Pricing and mix were both flat across segments.</li> <li>Operating profit margin fell 40 bps, despite productivity cost savings.</li> <li>Operating cash flow was $3.6B for the quarter, while free cash flow productivity was 87%.</li> <li>Looking ahead, P&amp;G sees FY18 organic sales growth of 2% to 3% and FY18 EPS of $4.12 to $4.19 vs. $4.18 consensus.</li><li>Shares of Procter &amp; Gamble are&nbsp;<font color='red'>down 1.60%</font>&nbsp;to $90.12.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302543-procter-and-gamble-beats-0_01-misses-revenue\" target=\"_blank\">Procter &amp; Gamble beats by $0.01, misses on revenue</a> (Oct. 20)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3302583\" data-linked=\"Light profit guidance from Procter &amp; Gamble\" data-tweet=\"$PG - Light profit guidance from Procter &amp; Gamble https://seekingalpha.com/news/3302583-light-profit-guidance-from-procter-gamble?source=tweet\" data-url=\"https://seekingalpha.com/news/3302583-light-profit-guidance-from-procter-gamble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302575\" data-ts=\"1508500681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STLD\" target=\"_blank\">STLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302575-steel-dynamics-up-premarket-keybanc-says-time-is-ripe-for-m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel Dynamics up premarket, KeyBanc says &#39;time is ripe&#39; for M&amp;A</a></h4><ul><li>KeyBanc upgrades Steel Dynamics (NASDAQ:<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>) to Overweight from Sector Weight, citing EPS potential from execution and organic growth, which will more than offset steel-making consumable cost increases.</li><li>Says&nbsp;\"time is ripe\" for more meaningful, perhaps transformational M&amp;A for STLD as forward net debt/Ebitda looking poised to fall under 1x in 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3302575\" data-linked=\"Steel Dynamics up premarket, KeyBanc says &#39;time is ripe&#39; for M&amp;A\" data-tweet=\"$STLD - Steel Dynamics up premarket, KeyBanc says &#39;time is ripe&#39; for M&amp;A https://seekingalpha.com/news/3302575-steel-dynamics-up-premarket-keybanc-says-time-is-ripe-for-m?source=tweet\" data-url=\"https://seekingalpha.com/news/3302575-steel-dynamics-up-premarket-keybanc-says-time-is-ripe-for-m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302572\" data-ts=\"1508500013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMDZ\" target=\"_blank\">IMDZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302572-immune-design-up-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immune Design up 7% premarket</a></h4><ul><li>Immune Design (NASDAQ:<a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a>) is up&nbsp;<font color='green'>7%</font>&nbsp;premarket on light volume giving beleaguered longs a ray of hope after a heavy four-day selloff. Yesterday, the European Commission designated G100 an Orphan Drug for follicular lymphoma.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302311-immune-designs-g100-orphan-drug-europe-follicular-lymphoma-shares-continue-slide-late-stage\" target=\"_blank\">Immune Design's G100 an Orphan Drug in Europe for follicular lymphoma; shares continue slide over late-stage study of CMB305, down 14%</a> (Oct. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302572\" data-linked=\"Immune Design up 7% premarket\" data-tweet=\"$IMDZ - Immune Design up 7% premarket https://seekingalpha.com/news/3302572-immune-design-up-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3302572-immune-design-up-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302571\" data-ts=\"1508499972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYPL\" target=\"_blank\">PYPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302571-paypal-up-nearly-4-post-earnings-bull-boosts-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PayPal up nearly 4% post-earnings; bull boosts price target</a></h4><ul><li>Not only did PayPal (NASDAQ:<a href='https://seekingalpha.com/symbol/PYPL' title='PayPal Holdings, Inc.'>PYPL</a>) show no signs its platform growth is slowing, but the growth rate is actually increasing as network effects take hold, <a href=\"http://researchwiseny.btig.com/ResearchLibraryAnalec/DownloadResearch.aspx?E=jjhak-b\" target=\"_blank\">says BTIG's Mark Palmer</a>.</li><li>Then there are initiatives like Venmo and One Touch which are still in the very early innings. There's also $7.1B in cash which could be used to fund M&amp;A, fueling what could be daunting global potential</li><li>He lifts his price target to $81 from $70.</li><li>Shares are&nbsp;<font color='green'>higher by 3.6%&nbsp;</font>premarket to $69.70.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302400-paypal-3_8-percent-topping-estimates\" target=\"_blank\">PayPal up 3.8% after topping estimates</a> (Oct. 19)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302362-paypal-beats-0_03-beats-revenue\" target=\"_blank\">PayPal beats by $0.03, beats on revenue</a> (Oct. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302571\" data-linked=\"PayPal up nearly 4% post-earnings; bull boosts price target\" data-tweet=\"$PYPL - PayPal up nearly 4% post-earnings; bull boosts price target https://seekingalpha.com/news/3302571-paypal-up-nearly-4-post-earnings-bull-boosts-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3302571-paypal-up-nearly-4-post-earnings-bull-boosts-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3302570\" data-ts=\"1508499772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDHL\" target=\"_blank\">RDHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3302570-redhill-biopharma-up-10-premarket-following-u-s-orphan-drug-tag-for-upamostat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RedHill Biopharma up 10% premarket following U.S. Orphan Drug tag for upamostat</a></h4><ul><li>RedHill Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a>) is up&nbsp;<font color='green'>10%</font>&nbsp;premarket on light volume. Yesterday, the FDA designed MESUPRON (upamostat) an Orphan Drug for the treatment of pancreatic cancer.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302268-redhills-upamostat-orphan-drug-u-s-pancreatic-cancer\" target=\"_blank\">RedHill's upamostat an Orphan Drug in U.S. for pancreatic cancer</a> (Oct. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3302570\" data-linked=\"RedHill Biopharma up 10% premarket following U.S. Orphan Drug tag for upamostat\" data-tweet=\"$RDHL - RedHill Biopharma up 10% premarket following U.S. Orphan Drug tag for upamostat https://seekingalpha.com/news/3302570-redhill-biopharma-up-10-premarket-following-u-s-orphan-drug-tag-for-upamostat?source=tweet\" data-url=\"https://seekingalpha.com/news/3302570-redhill-biopharma-up-10-premarket-following-u-s-orphan-drug-tag-for-upamostat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}